WO2023132104A1 - Liquid drug administration device, method for controlling same, and liquid drug administration system - Google Patents

Liquid drug administration device, method for controlling same, and liquid drug administration system Download PDF

Info

Publication number
WO2023132104A1
WO2023132104A1 PCT/JP2022/034106 JP2022034106W WO2023132104A1 WO 2023132104 A1 WO2023132104 A1 WO 2023132104A1 JP 2022034106 W JP2022034106 W JP 2022034106W WO 2023132104 A1 WO2023132104 A1 WO 2023132104A1
Authority
WO
WIPO (PCT)
Prior art keywords
solution
movable
reservoir
administration device
drug
Prior art date
Application number
PCT/JP2022/034106
Other languages
French (fr)
Japanese (ja)
Inventor
祐介 薬師寺
Original Assignee
テルモ株式会社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by テルモ株式会社 filed Critical テルモ株式会社
Publication of WO2023132104A1 publication Critical patent/WO2023132104A1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142Pressure infusion, e.g. using pumps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142Pressure infusion, e.g. using pumps
    • A61M5/145Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • A61M5/31Details
    • A61M5/315Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms

Definitions

  • the present disclosure relates to a medical solution administration device, its control method, and a medical solution administration system.
  • Patent Literature 1 describes a configuration related to a drug-solution administration device.
  • An object of the present disclosure is to provide a drug-solution administration device, a control method thereof, and a drug-solution administration system capable of shortening the time required to restart drug-solution administration when the drug-solution administration is interrupted.
  • a medical-solution administration device is a medical-solution administration device that administers a medical solution filled in a reservoir into a living body by a pressing action of a plunger, comprising: the reservoir filled with the medical solution; the plunger that is provided in the reservoir and is movable in the longitudinal direction of the reservoir; a movable portion that is capable of pressing the plunger toward the distal end side of the reservoir by moving in the movable region; a driving unit that moves in an area; a detection unit that can detect the movable unit at a predetermined detection position in the movable area; The movable part is moved in a direction opposite to the distal end side until the detection part detects the movable part, and based on a first movement amount, which is a movement amount in the opposite direction, the chemical solution remains in the reservoir.
  • Estimate quantity is a first movement amount, which is a movement amount in the opposite direction, the chemical solution remains in the reservoir.
  • control section moves the movable section from the detection position to the distal end side by the first movement amount, and after the movement, until the flow path in the liquid medicine administration device is filled with the liquid medicine. and controlling the drive unit so as to move the movable unit toward the distal end by a second movement amount and then restart the administration of the liquid medicine.
  • the driving section moves the movable section by transmitting a driving force based on the rotation of a motor
  • the control section controls the detection position and the movable section by the first movement amount. and the number of rotations of the motor required for moving the movable portion by the second movement amount.
  • a plurality of the detection units capable of detecting the movable portion at the detection positions different from each other are provided, and the control unit responds to resuming the interrupted drug solution administration. Then, the movable portion is moved in a direction opposite to the distal end side until any one of the plurality of detection portions detects the movable portion.
  • a disposable cartridge and a reusable device main body detachably provided on the cartridge are provided, and the reservoir, the plunger, the movable part, the driving part, the detection part, and the A control unit is provided in each of the cartridge and the device main body, and the control unit controls the detection position at the detection position in response to reconnection of the cartridge and the device main body that were disconnected during drug solution administration.
  • the movable part is moved in a direction opposite to the distal end side until the detection part detects the movable part, the residual amount of the chemical solution in the reservoir is estimated based on the first movement amount, and the residual amount is Based on this, the driving unit is controlled so as to restart the administration of the liquid medicine.
  • the estimated remaining amount of the chemical liquid is displayed on the display device.
  • a medical-solution administration system includes the medical-solution administration device described above and a remote control for a user to operate the medical-solution administration device.
  • a control method for a drug-solution administration device includes a reservoir filled with a drug solution, a plunger provided in the reservoir and movable in the longitudinal direction of the reservoir, and a plunger moving in a movable region. a movable part capable of pressing the plunger toward the distal end of the reservoir; a driving part for moving the movable part in the movable area; and detecting the movable part at a predetermined detection position in the movable area.
  • FIG. 10 is a diagram showing an example of a cartridge in which the nut portion is in the non-contact position;
  • FIG. 10 is a diagram showing an example of a cartridge with a nut portion in a predetermined position;
  • FIG. 2 is a block diagram showing an example of a configuration related to control of the drug-solution administration device of FIG. 1;
  • FIG. 2 is a block diagram showing an example of the hardware configuration of the remote control shown in FIG. 1;
  • FIG. 2 is a flow chart showing an operation procedure of the drug-solution administration device of FIG.
  • 2 is a flow chart showing an operation procedure of the drug-solution administration device of FIG. 1; 2 is a flow chart showing an operation procedure of the drug-solution administration device of FIG. 1; 2 is a flow chart showing an operation procedure of the drug-solution administration device of FIG. 1;
  • FIG. 1 is a diagram showing an example of a drug-solution administration system 100 according to one embodiment.
  • the drug solution administration system 100 administers a drug solution such as insulin into the patient's body.
  • a drug-solution administration system 100 includes a drug-solution administration device 10 and a remote controller 90 .
  • the drug solution administration device 10 is a device that continuously or intermittently administers the drug solution filled in the reservoir into the living body by the pressing action of the plunger.
  • the drug-solution administration device 10 may be, for example, a portable device that can be attached to the patient's abdomen (patch type).
  • the drug-solution administration device 10 is not limited to a patch type, and may be a tube type or the like.
  • the remote control 90 is a device for a user such as a patient to operate the drug-solution administration device 10 .
  • the remote controller 90 notifies the user of information received from the medical-solution administration device 10 and accepts user's operations on the medical-solution administration device 10 .
  • the remote controller 90 is implemented by a dedicated device compatible with the drug-solution administration device 10, but may be implemented by a general-purpose information processing device such as a smart phone or a tablet. Further, in this embodiment, an example in which the remote controller 90 serves as a user interface such as notifying the user of information and receiving information input from the user will be described.
  • the functions may be provided in the drug-solution administration device 10 .
  • the medicinal-solution administration device 10 and the remote controller 90 are communicably connected to each other via a wireless communication line, a wired communication line, or a combination thereof.
  • a wireless communication line a wireless communication line
  • a wired communication line a wired communication line
  • FIG. 2 is a diagram showing an example of an exploded perspective view of the drug-solution administration device 10 of FIG.
  • FIG. 3 shows an example of the cartridge 12 with the nut portion 24 at the non-contact position.
  • FIG. 4 shows an example of the cartridge 12 with the nut portion 24 at a predetermined position.
  • the drug-solution administration device 10 includes a disposable cartridge 12 and a reusable device main body 14.
  • the cartridge 12 has a flat box-shaped base portion 16 which is open on one side.
  • the base portion 16 has a substantially rectangular shape in plan view.
  • the base portion 16 may be detachably provided to a cradle (not shown) that can be attached to the patient's skin.
  • the cradle may include a cannula that is left in vivo.
  • the base portion 16 includes a reservoir 18 filled with a chemical solution, a plunger 20 provided in the reservoir 18, a feed screw shaft 22 coaxially arranged with the plunger 20, and a feed screw shaft.
  • a nut portion (movable portion) 24 that is screwed onto 22 is provided.
  • Base portion 16 is configured as a disposable member.
  • the reservoir 18 extends cylindrically in the longitudinal direction of the base portion 16 .
  • the distal end portion of the reservoir 18 has an outer diameter and an inner diameter that decrease toward the distal end.
  • An introduction port 26 for introducing the chemical solution into the reservoir 18 and an extraction port 28 (see FIG. 3) for extracting the chemical solution from the reservoir 18 are formed at the tip of the reservoir 18. .
  • the lead-out port 28 communicates with a lead-out tube 29 that guides the drug solution in the reservoir 18 to the cannula.
  • the plunger 20 is integrally formed of a resin material or the like, and is provided in the reservoir 18 so as to be liquid-tight and slidable along the axial direction of the reservoir 18 .
  • the plunger 20 has a plunger main body 30 forming a tip side, and a pusher 32 provided on the plunger main body 30 and forming a rear end side.
  • a seal member 34 is attached to the rear end side of the plunger main body 30 which is formed in a cylindrical shape.
  • the pusher 32 has a pair of extensions 36 extending rearward from the plunger body 30 to the outside of the reservoir 18 and a pair of claws 38 provided at the rear ends of the extensions 36 .
  • One end of the feed screw shaft 22 is rotatably supported by a bearing 39 and constitutes a drive section 40 that moves the nut section 24 .
  • the drive unit 40 includes a battery 42 as a power source, a motor 44 driven by the battery 42, a gearbox (power transmission mechanism) 46 that reduces the rotational driving force of the motor 44 and transmits it, and an output gear 48 of the gearbox 46. It further has a transmission shaft 52 to which a spur gear 50 meshing with is fixed and locked to the feed screw shaft 22 so as to be integrally rotatable.
  • the battery 42 and transmission shaft 52 are provided in the cartridge 12, and the motor 44 and gear box 46 are provided in the device body 14.
  • the battery 42 is provided with a terminal 54 electrically connected to the motor 44 of the device body 14 when the device body 14 is connected to the cartridge 12 .
  • the transmission shaft 52 is supported by a pair of bearings 56 provided on the base portion 16 while being coaxial with the feed screw shaft 22 .
  • the motor 44 When the motor 44 rotates, its rotational force is transmitted to the feed screw shaft 22 , and the rotation of the feed screw shaft 22 causes the nut portion 24 to move toward or away from the plunger 20 .
  • the rotation of the motor 44 for moving the nut portion 24 toward the plunger 20 will be referred to as forward rotation
  • the rotation of the motor 44 in the direction opposite to the forward rotation will be referred to as reverse rotation.
  • the motor 44 is configured to rotate both forward and reverse.
  • the motor 44 is configured so that the rotational driving force is not transmitted to the components below the gear box 46 when a certain force or more is applied to the forward or reverse rotation.
  • a stepping motor for example, may be employed as the motor 44 .
  • a rotary encoder (not shown) is provided on the output shaft of the motor 44, and it is possible to determine whether the motor 44 is out of sync with the input pulse (step out) by detecting the rotation of the motor 44 with the rotary encoder. The operating state of the motor 44 is transmitted to the control section 71 as a rotary encoder output.
  • the nut portion 24 is integrally molded from a resin material and has a nut portion main body 58 formed in a substantially rectangular parallelepiped shape and a slide portion 60 provided on the nut portion main body 58 .
  • the nut main body 58 is formed with a threaded hole 62 into which the feed screw shaft 22 is screwed, and a pair of through holes 64 which are formed to sandwich the threaded hole 62 from both sides and through which the claws 38 are inserted.
  • a reinforcing cover 66 made of, for example, a metal material is attached to the outer surface of the nut body 58 .
  • the slide portion 60 slides on a guide wall 68 provided on the base portion 16 and extending along the axial direction of the plunger 20 . That is, the nut portion 24 is in a non-contact position (see FIG. 3) where it does not contact the plunger 20 before use. Then, the plunger 20 is pushed forward (see FIG. 4).
  • the apparatus main body 14 includes a lid body 70 detachably provided on the base portion 16 so as to close the opening of the base portion 16, a control portion 71, a storage portion 72, A communication unit 73 , a position detection unit 74 , and an orientation detection unit 75 are provided.
  • the motor 44, storage unit 72, communication unit 73, position detection unit 74, and orientation detection unit 75 are electrically connected to the control unit 71 via a bus 79 (see FIG. 5).
  • the control unit 71 controls each part of the medicinal-solution administration device 10 and executes processing related to the operation of the medicinal-solution administration device 10 .
  • the control unit 71 drives and controls the motor 44 based on information regarding drug solution administration transmitted from the remote controller 90 .
  • the position detection portion (detection portion) 74 is a sensor that detects the position of the nut portion 24 in the axial direction of the plunger 20 .
  • the position detection section 74 may detect the position of the nut section 24 by detecting the position of the slide section 60 on the guide wall 68, for example.
  • the position detection part 74 is provided at intervals along the guide wall 68, and is capable of detecting the nut part 24 at each corresponding detection position. may be configured.
  • Each of the plurality of position detection units 74a to 74d may be realized by contact sensors, for example. In this case, the position detection section 74 can detect the position of the nut section 24 corresponding to one of the plurality of contact sensors based on detection of the contact of the slide section 60 .
  • the position detection portion 74 By configuring the position detection portion 74 as a plurality of position detection portions 74a to 74d in this manner, the position of the nut portion 24 in the axial direction of the plunger 20 can be easily detected.
  • the configuration of the position detection portion 74 is not limited to a contact sensor configuration as long as the position of the nut portion 24 can be detected.
  • a configuration using a non-contact sensor using magnetic field detection combining a magnetic field generation source such as a magnet and a Hall element, or light detection combining a light source such as an LED and a light receiving element, or the like may be used.
  • position detection of the slide portion 60 and position detection of the nut portion 24 are synonymous.
  • FIG. 5 is a block diagram showing an example of a configuration related to control of the medicinal-solution administration device 10 of FIG.
  • the motor 44 , the storage unit 72 , the communication unit 73 , the position detection unit 74 , and the orientation detection unit 75 are electrically connected to the control unit 71 via the bus 79 .
  • the control unit 71 is one or more processors.
  • the control unit 71 is communicably connected to each component constituting the drug-solution administration device 10 and controls the operation of the drug-solution administration device 10 as a whole.
  • the processor is a general-purpose processor such as a CPU (Central Processing Unit) or a dedicated processor specialized for specific processing.
  • the controller 71 may include one or more dedicated circuits, or one or more processors may be replaced with one or more dedicated circuits in the controller 71 .
  • the dedicated circuit is, for example, an FPGA (Field Programmable Gate Array).
  • the storage unit 72 is one or more semiconductor memories, one or more magnetic memories, one or more optical memories, or a combination of at least two of them.
  • the semiconductor memory is, for example, RAM (Random Access Memory) or ROM (Read Only Memory).
  • the storage unit 72 functions as, for example, a main memory device, an auxiliary memory device, or a cache memory.
  • the storage section 72 may store information from the control section 71 .
  • Information stored in storage unit 72 may be transmitted to remote controller 90 via communication unit 73 under the control of control unit 71 .
  • the communication unit 73 is a communication interface for communicating with the remote control 90.
  • the communication unit 73 communicates with the remote controller 90 via Bluetooth (registered trademark), but is not limited to this, and communicates via other wireless communication paths such as a wireless LAN (Local Area Network) or a wired cable, for example. You may
  • the medicinal-solution administration device 10 may be provided with a posture detection unit 75 that is a device for detecting the posture of the medicinal-solution administration device 10 .
  • the orientation detection unit 75 may be realized by a triaxial acceleration sensor, a gyro sensor, or the like.
  • Control of the medicinal-solution administration device 10 may be executed by executing a program by a processor included in the control unit 71 . That is, the control of the drug-solution administration device 10 may be realized by software. In this case, the program causes the computer to execute the processing of steps included in the operation of the drug-solution administration device 10, thereby causing the computer to implement the functions corresponding to the processing of the steps. Alternatively, part or all of the functions of the medicinal-solution administration device 10 may be implemented by a dedicated circuit included in the control section 71 . That is, part or all of the functions of the drug-solution administration device 10 may be realized by hardware. (Remote control configuration)
  • FIG. 6 is a block diagram showing an example of the hardware configuration of the remote control 90 of FIG. 1. As shown in FIG.
  • the remote controller 90 includes a control section 91 , a storage section 92 , a communication section 93 , an input section 94 , an output section 95 and a bus 99 .
  • the control unit 91 is one or more processors.
  • the control unit 91 is communicably connected to each constituent unit of the remote controller 90 via a bus 99 and controls the operation of the remote controller 90 as a whole.
  • the processor is a general-purpose processor such as a CPU or GPU (Graphics Processing Unit), or a dedicated processor specialized for specific processing.
  • Control unit 91 may include one or more dedicated circuits, or one or more processors may be replaced by one or more dedicated circuits in control unit 91 .
  • a dedicated circuit is, for example, an FPGA.
  • the storage unit 92 is one or more semiconductor memories, one or more magnetic memories, one or more optical memories, or a combination of at least two of them.
  • a semiconductor memory is, for example, a RAM or a ROM.
  • RAM is, for example, SRAM (Static RAM) or DRAM (Dynamic RAM).
  • the ROM is, for example, an EEPROM (Electrically Erasable Programmable ROM).
  • the storage unit 92 functions, for example, as a main storage device, an auxiliary storage device, or a cache memory.
  • the communication unit 93 is a communication interface for communicating with the drug-solution administration device 10.
  • the communication unit 93 communicates with the medicinal-solution administration device 10 to transmit information input by the user to the medicinal-solution administration device 10 and receive information from the medicinal-solution administration device 10 .
  • the communication unit 93 communicates with the medicinal-solution administration device 10 via, for example, Bluetooth (registered trademark), but is not limited to this, and may communicate via other wireless communication paths such as wireless LAN or wired cables, for example.
  • the input unit 94 includes one or more input interfaces that receive user's input operations and acquire input information based on the user's operations.
  • the input unit 94 is, for example, a touch screen provided integrally with the display (display device) of the output unit 95, but is not limited to this, physical keys (eg, external numeric keypad), capacitance keys, pointing It may be a device or a microphone or the like that receives voice input.
  • the output unit 95 as a display unit outputs information to the user and includes one or more output interfaces for notifying the user.
  • the output unit 95 is a display that outputs information by image display, an LED (Light Emitting Diode), a speaker, a vibrator, or the like, but is not limited to these.
  • the functions of the remote control 90 may be realized by executing the program according to the present embodiment with a processor included in the control unit 91. That is, the functions of the remote control 90 may be realized by software. In this case, the program causes the computer to execute the processing of steps included in the operation of the remote control 90, thereby causing the computer to implement the functions corresponding to the processing of the steps.
  • some or all of the functions of remote controller 90 may be realized by a dedicated circuit included in control section 91 . That is, some or all of the functions of remote control 90 may be realized by hardware.
  • the user adjusts the position of the plunger 20 with respect to the reservoir 18 and fills the reservoir 18 with an arbitrary amount of drug solution from the introduction port 26 from a drug solution container such as a vial in which the drug solution is hermetically stored.
  • the user connects the device main body 14 to the cartridge 12 (initial connection).
  • the power of the battery 42 of the cartridge 12 is supplied to the components of the device main body 14 , and the output gear 48 of the gear box 46 of the device main body 14 meshes with the spur gear 50 of the cartridge 12 .
  • the control unit 71, the storage unit 72, and the like are activated by being supplied with power from the battery 42.
  • the first priming is an operation performed on the drug solution administration device 10 immediately after the cartridge 12 taken out of the packaging container is filled with the drug solution and the cartridge 12 and the device main body 14 are connected. is engaged with the plunger 20 and the flow channel is filled with the chemical solution.
  • the remote controller 90 is operated to rotate the motor 44 forward.
  • the rotational driving force of the motor 44 is transmitted to the feed screw shaft 22 via the gear box 46, the spur gear 50, and the transmission shaft 52, so that the feed screw shaft 22 rotates, and the nut portion 24 moves toward the guide wall. While sliding 68, it advances to the plunger 20 side.
  • the pair of claw portions 38 hits the wall surface forming the through hole 64 of the nut portion 24, and the pair of extension portions 36 are bent so as to approach each other.
  • the extension portion 36 returns from the bent state to its original state, and the nut portion 24 is locked to the rear end portion of the plunger 20 .
  • the nut portion 24 can press the plunger 20 toward the distal end side.
  • the chemical solution in the reservoir 18 is pressed against the plunger 20, and the inner hole of the lead-out tube 29 is filled with the chemical solution, completing the first priming.
  • This first priming is completed when the user visually recognizes that the drug solution is discharged from the connecting needle tube that is fluidly connected to the outlet tube 29 and exposed to the outside of the drug solution administration device 10 .
  • the position where the nut portion 24 is locked with respect to the plunger 20 corresponds to the initial filling amount of the chemical solution.
  • the user attaches a cradle (not shown) to a predetermined position on the skin. Then, the user uses the puncture mechanism to leave the cannula in the living body through the opening of the cradle. Next, the user attaches the drug solution administration device 10, in which the cartridge 12 and the device main body 14 are connected, to the cradle, so that the connecting needle tube and the cannula communicate with each other.
  • the drug solution administration device 10 in which the cartridge 12 and the device main body 14 are connected, to the cradle, so that the connecting needle tube and the cannula communicate with each other.
  • the control unit 71 controls the rotation of the motor 44 in accordance with the drug solution administration schedule instructed from the remote controller 90, and administers the drug solution at various rates such as a basal rate or a bolus according to the patient's condition.
  • the basal rate is the amount of drug solution per unit time corresponding to basal secretion.
  • a bolus is the amount of drug solution that provides additional secretion in response to a meal or an increase in blood sugar level.
  • the drug solution filled in the reservoir 18 of the cartridge 12 is administered into the body over, for example, several days to one week, and the cartridge 12 is replaced after the administration period has passed.
  • the cartridge 12 is replaced, filling of the reservoir 18 of the cartridge 12 with the chemical solution, connection of the cartridge 12 and the apparatus main body 14, and first priming are performed.
  • the medicinal-solution administration device 10 uses the position where the nut part 24 is locked by the plunger 20 at the time of completion of the first priming as a reference.
  • the amount of the administered liquid medicine also referred to as an estimated dose amount
  • the remaining amount of the liquid medicine can be estimated.
  • the administration history of the medicinal-solution administration device 10 may be managed by the remote controller 90 from the viewpoint of preventing misuse of the medicinal-solution administration device 10 and mistaken administration history data.
  • the storage unit 72 of the device body 14 may be configured to be erased when the power supply is interrupted. As a result, the control unit 71 and the storage unit 72 of the device main body 14 can reduce the amount of data to be held without identifying a plurality of cartridges by individual IDs or the like, so that the cost of the drug-solution administration device 10 can be reduced. can be done.
  • the medical solution administration operation may be unintentionally interrupted.
  • the control unit 71, storage unit 72, etc. and the drug-solution administration device 10 stops operating.
  • the administration history stored in the storage unit 72 without being transmitted to the remote controller 90 is reset.
  • the initial filling amount information based on the position of the nut portion 24 at the time of completion of the first priming, the estimated amount of administration, or the residual amount of the liquid medicine can be obtained. Since the amount information and the like are lost, the medical-solution administration device 10 cannot accurately know the replacement timing of the cartridge 12 based on the remaining amount.
  • the plunger 20 may move when the user touches the plunger 20 while the cartridge 12 and the apparatus main body 14 are disconnected. However, there may be a case where the information does not match the information in the storage unit 72 or the like.
  • the medicinal-solution administration device in order to grasp the position of the plunger 20, the medicinal-solution administration device brings the nut portion 24 into contact with the bearing 56, which is the initial position, and then moves the nut portion 24 until the medicinal solution is discharged from the connecting needle tube. It is also possible to move in the ejection direction.
  • the drug-solution administration device may be set to the initial position when the slide portion 60 is moved to the end portion of the guide wall 68 .
  • a restricting portion may be provided at the end of the guide wall 68 so that the sliding portion 60 cannot move any further.
  • the medicinal-solution administration device can detect whether or not the nut portion 24 has reached the initial position based on whether or not the motor 44 has stepped out.
  • the medicinal-solution administration device 10 includes a position detection portion 74 that detects the position of the nut portion 24 on the side of the medicinal-solution discharge direction relative to the initial position of the nut portion 24 .
  • the medical-solution administration device 10 performs the second priming when the cartridge 12 and the device main body 14 are reconnected.
  • the second priming refers to an operation of detecting the position of the nut portion 24 of the drug solution administration device 10 immediately after the cartridge 12 and the device main body 14 are reconnected, and filling the channel with the drug solution.
  • the medical-solution administration device 10 causes the motor 44 to reversely rotate faster than usual until the position of the nut portion 24 can be detected by the position detection portion 74 to retract the nut portion 24 .
  • the drug-solution administration device 10 rotates the motor 44 forward faster than usual by the same number of rotations as the number of rotations of the reverse rotation to push the nut part 24 forward. , the nut portion 24 is advanced until the drug solution is discharged from the connecting needle tube. In this manner, when the cartridge 12 and the device main body 14 are reconnected, the drug-solution administration device 10 does not return the nut portion 24 to the initial position, but retreats until the position can be detected. advance until the medicinal solution is discharged from the connected needle tube. Therefore, according to the medicinal-solution administration device 10, it is possible to shorten the time required to restart the medicinal-solution administration.
  • FIGS. 7 to 10 are flowcharts showing the operation procedure of the medicinal-solution administration device 10 of FIG.
  • the operation of the medical-solution administration device 10 described with reference to FIGS. 7 to 10 can correspond to one control method of the medical-solution administration device 10.
  • FIG. 7 to 10 can be executed under the control of the control unit 71 of the drug-solution administration device 10 or the control unit 91 of the remote controller 90.
  • FIG. The following processing is executed in response to detection of connection again after the connection between the device main body 14 of the drug-solution administration device 10 and the cartridge 12 has been released.
  • the cartridge 12 is connected for the first time, the nut portion 24 is at the non-contact position, and the motor 44 is immediately out of step at the initial position due to the reverse rotation.
  • the control unit 71 of the medicinal-solution administration device 10 determines whether or not step-out due to the reverse rotation of the motor 44 occurs in a program that is activated when the device main body 14 and the cartridge 12 are connected and power is supplied from the battery 42 . , it is possible to determine whether the connection between the apparatus main body 14 and the cartridge 12 is the initial connection or the reconnection.
  • step S1 of FIG. 7 the control unit 91 of the remote controller 90 detects from the output unit 95 that the connection between the device main body 14 of the drug-solution administration device 10 and the cartridge 12 has been disconnected, and that the connection has been detected again. is notified to the user.
  • the control unit 91 may notify by displaying on the display that disconnection and reconnection between the apparatus main body 14 and the cartridge 12 have been detected.
  • the control unit 91 may notify that effect.
  • the control unit 71 of the medicinal-solution administration device 10 is connected via the communication unit 73 in a program that is activated when the device main body 14 and the cartridge 12 are connected and power is supplied from the battery 42. may be notified to the remote controller 90 . In that case, the medical-solution administration device 10 may determine whether the connection is reconnection of the device main body 14 and the cartridge 12 based on the user's selection via the input unit 94 .
  • step S2 the control unit 91 of the remote controller 90 notifies the user that maintenance processing will be executed.
  • the control unit 91 may display on the display of the output unit 95 that maintenance processing is to be performed.
  • the maintenance processing here refers to execution of the second priming accompanying reconnection of the cartridge 12 and the apparatus main body 14 .
  • step S3 the control unit 91 of the remote controller 90 notifies the user to place the medicinal-solution administration device 10 vertically after removing it from the cradle.
  • a cradle detection switch may be provided in the medical-solution administration device 10 to determine disconnection from the cradle.
  • the control unit 91 may display on the display of the output unit 95 an image prompting the user to hold the medical-solution administration device 10 so that the outlet port 28 is positioned vertically above the reservoir 18 .
  • step S4 may be suspended until the posture of is appropriate.
  • step S4 the control unit 91 of the remote controller 90 notifies the user to select the start button.
  • the control unit 91 may display an image prompting selection of the start button of the input unit 94 on the display of the output unit 95 .
  • the input unit 94 is a touch screen provided integrally with the display of the output unit 95
  • the control unit 91 displays an image of the start button on the display of the output unit 95, and displays an image prompting the selection.
  • step S5 the control unit 91 of the remote controller 90 determines whether or not the start button has been selected by the user. If the start button is selected (YES in step S5), the control unit 91 proceeds to step S11 in FIG. 8, otherwise (NO in step S5), it waits until the start button is selected.
  • the control unit 71 of the medicinal-solution administration device 10 rotates the motor 44 in the reverse direction. That is, the control section 71 rotates the motor 44 so as to move the nut section 24 in the direction opposite to the discharge direction of the chemical solution. Reverse rotation of the motor 44 draws air into the reservoir 18 from the connecting needle. The rotation speed of this reverse rotation may be greater than the normal rotation speed when administering the drug solution. As a result, it is possible to restart administration of the liquid medicine in a short time.
  • the control unit 71 may perform the process of step S11 in response to receiving the notification that the start button has been selected from the communication unit 93 of the remote controller 90 by the communication unit 73 of the drug-solution administration device 10 .
  • step S12 the control unit 71 of the medicinal-solution administration device 10 determines whether or not the motor 44 is out of step, or contact between the slide unit 60 and any of the contact sensors 74a to 74d is detected. If the control unit 71 detects the step-out of the motor 44 or the contact of the slide unit 60 (YES in step S12), the process proceeds to step S13. Continue reverse rotation. Detection of step-out of the motor 44 means that the nut portion 24 has reached the initial position.
  • step S ⁇ b>13 the control unit 71 of the medicinal-solution administration device 10 stops the reverse rotation of the motor 44 .
  • step S14 the control unit 71 of the medicinal-solution administration device 10 acquires the number of revolutions M of the motor 44 from the start of the reverse rotation of the motor 44 in step S11 to the stop of the reverse rotation of the motor 44 in step S13.
  • the control unit 71 notifies the remote controller 90 of the obtained number of rotations M and the position at which the step-out of the motor 44 or the contact of the slide unit 60 is detected. Then, the controller 71 proceeds to step S21 in FIG.
  • step S21 the control unit 71 of the medicinal-solution administration device 10 determines whether or not the medicinal-solution administration device 10 faces a predetermined direction. That is, the control unit 71 determines whether or not the medical-solution administration device 10 is maintained in the direction in which the lead-out port 28 is positioned vertically above the reservoir 18 based on the posture of the medical-solution administration device 10 detected by the posture detection unit 75 . do. This determination is made to prevent the liquid medicine from being discharged from the connecting needle before the air due to the forward rotation of the motor 44 when the posture of the liquid medicine administration device 10 is not maintained. If the control unit 71 determines that the medicinal-solution administration device 10 faces the predetermined direction (YES in step S21), the process proceeds to step S22; otherwise (NO in step S21), the process proceeds to step S25.
  • step S22 the control unit 71 of the medicinal-solution administration device 10 causes the motor 44 to rotate forward.
  • the rotational speed of the motor 44 may be, for example, higher than the normal rotational speed when administering the liquid medicine, similar to the reverse rotation of the motor 44 in step S11 of FIG.
  • the forward rotation speed in step S22 may be the same as the reverse rotation speed in step S11.
  • step S23 the control unit 71 of the medicinal-solution administration device 10 determines whether or not the number of forward rotations of the motor 44 in step S22 is M. If the forward rotation number is M (YES in step S23), the control unit 71 proceeds to step S24, otherwise (NO in step S23), proceeds to step S21.
  • step S24 the control unit 71 of the medicinal-solution administration device 10 stops forward rotation of the motor 44. Then, the controller 71 proceeds to step S31 in FIG.
  • step S25 if the motor 44 is rotating, the control unit 71 of the medicinal-solution administration device 10 stops the rotation. That is, after starting forward rotation of the motor 44 in step S22, before the number of revolutions reaches M, if the posture of the drug-solution administration device 10 deviates from the predetermined direction, the control unit 71 stops the rotation of the motor 44. At the same time, the remote controller 90 is notified to that effect.
  • step S26 the control unit 91 of the remote controller 90 notifies the user to turn the drug-solution administration device 10 vertically.
  • the control unit 91 may display on the display of the output unit 95 an image prompting the user to hold the medical-solution administration device 10 so that the lead-out port 28 is positioned vertically above the reservoir 18, as in step S3. good.
  • the control unit 91 may make such notification in response to receiving from the medicinal-solution administration device 10 a notification that the posture of the medicinal-solution administration device 10 has deviated from the predetermined direction.
  • the process returns to step S21, and the control unit 71 of the medicinal-solution administration device 10 confirms the attitude of the medicinal-solution administration device 10.
  • step S31 of FIG. 10 the control unit 91 of the remote controller 90 notifies the user to select the liquid feed button and confirm the discharge of the liquid medicine.
  • This ejection of the chemical liquid fills the flow path of the chemical liquid administration device 10 in the second priming with the chemical liquid.
  • the control section 91 may display on the display of the output section 95 an image prompting the user to select the liquid feeding button of the input section 94 .
  • the input unit 94 is a touch screen provided integrally with the display of the output unit 95
  • the control unit 91 displays an image of the liquid feeding button on the display of the output unit 95, and displays an image prompting selection thereof. You may The control unit 91 may prompt the user to discharge the liquid medicine in response to receiving the notification that the motor 44 has been stopped from the liquid medicine administration device 10 in step S24.
  • step S32 the control unit 71 of the medicinal-solution administration device 10 rotates the motor 44 forward by a constant number of rotations N each time the liquid feeding button is selected on the remote controller 90, thereby discharging the medicinal solution in the reservoir 18 into the lead-out tube 29. Move to inner hole.
  • the control unit 71 may rotate the motor 44 in the forward direction at a slower speed than the forward rotation in step S22 of FIG.
  • the control unit 91 of the remote controller 90 displays an image (for example, a confirmation button) for notifying the liquid medicine administration device 10 of this on the display of the output unit 95. good too.
  • step S33 the control unit 91 of the remote controller 90 determines whether or not the user has notified from the input unit 94 that the discharge of the liquid medicine has been confirmed. If the confirmation of liquid medicine discharge has been notified (YES in step S33), the controller 91 proceeds to step S34; otherwise (NO in step S33), it returns to step S31.
  • step S34 the control unit 91 of the remote controller 90 selects a reservoir from the total number of normal rotations of the motor 44 and the initial position or the position of any one of the contact sensors 74a to 74d where the contact of the nut portion 24 or the slide portion 60 is detected. Estimate the remaining amount (filling amount) of the chemical solution in 18 .
  • the total number of forward rotations of the motor 44 is the total number of rotations of the motor 44 since the forward rotation of the motor was started in step S22. That is, the total number of forward rotations of the motor 44 is obtained by combining M obtained in step S14 of FIG. is the sum (M+N ⁇ number of selections) with the value multiplied by .
  • the movement distance L of the nut portion 24 caused by one rotation of the motor 44 may be stored in advance in the memory portion 92 (or the memory portion 72). In that case, the controller 91 may obtain the moving distance of the nut part 24 by L ⁇ (M+N ⁇ the number of selections).
  • the initial position of the nut portion 24 or the position of the nut portion 24 corresponding to the contact positions of the contact sensors 74a to 74d may also be stored in advance in the storage portion 92 (or the storage portion 72).
  • the initial positions or the positions of the contact sensors 74a to 74d are set so as to correspond to a predetermined amount of chemical solution.
  • control unit 91 corresponds to (1) the initial position reached by the nut portion 24 or the contact sensor 74 first after the reverse rotation is started, and (2) the initial position reached by the nut portion 24 or the contact sensor 74. (3) the total number of positive rotations of the motor 44 (M + N ⁇ number of selections) or the movement distance L of the nut portion 24 at the completion of the second priming; and (4) per rotation of the motor 44 or Based on at least one of the discharge amount of the chemical solution per unit movement distance of the nut portion 24, the remaining amount of the chemical solution can be estimated and obtained.
  • control unit 91 multiplies the total positive number of rotations of the motor 44 by the discharge amount of the chemical liquid per one rotation of the motor 44, at the initial position of the nut part 24 or the position of the plunger 20 when the contact sensor 74 reaches.
  • the residual amount of the chemical solution may be estimated by subtracting it from the amount of the chemical solution that can be filled in the reservoir 18 .
  • control unit 91 obtains the position of the nut portion 24 by subtracting the movement distance L of the nut portion 24 from the initial position reached by the nut portion 24 or the position of the contact sensor 74, and calculates the remaining amount of the chemical solution in the reservoir 18. can be estimated.
  • the correspondence relationship between the position of the nut portion 24 and the remaining amount of the chemical solution is stored in advance in the storage unit 92 (or the storage unit 72), and the control unit 91 refers to the correspondence relationship to determine the remaining amount of the chemical solution. can be estimated.
  • step S35 the control unit 91 of the remote controller 90 displays the residual amount (filling amount) of the chemical liquid estimated in step S34 on the display of the output unit 95. Then, the control unit 91 ends the processing of the flowchart.
  • the drug solution administration device 10 that administers the drug solution filled in the reservoir 18 into the living body by the pressing action of the plunger 20 includes the reservoir 18, the plunger 20, the nut portion 24, the drive portion 40, the position detection portion 74, and the A control unit 71 is provided.
  • the reservoir 18 is filled with the chemical solution.
  • a plunger 20 is provided within the reservoir 18 and is movable in the longitudinal direction of the reservoir 18 .
  • the nut portion 24 can press the plunger 20 toward the distal end of the reservoir 18 by moving in the movable region.
  • the driving part 40 moves the nut part 24 in the movable area.
  • the position detection portion 74 can detect the nut portion 24 at a predetermined detection position in the movable area.
  • control unit 71 moves the nut part 24 in the direction opposite to the distal end side until the position detection part 74 detects the nut part 24 at the detection position. move.
  • the control unit 71 estimates the remaining amount of the liquid medicine in the reservoir 18 based on the first movement amount, which is the amount of movement in the opposite direction, and operates the driving unit 40 so as to restart administration of the liquid medicine based on the remaining amount. Control.
  • the nut portion 24 is moved in the direction opposite to the distal end side until the position detection portion 74 detects the nut portion 24 instead of the initial position. , the remaining amount of the chemical solution is estimated based on the amount of movement, and the administration of the chemical solution is resumed. Therefore, according to the medical-solution administration device 10 according to the present embodiment, it is possible to shorten the time required to resume the administration of the medical-solution when the administration of the medical-solution is interrupted.
  • the second priming can be performed by the position detection unit 74 provided at a position closer to the outlet port 28 than when performing the second priming at the initial position. Therefore, the time and power consumption required for the second priming can be greatly reduced.
  • the amount of movement of the nut portion 24 is indicated by, for example, the number of rotations of the motor 44, but may be indicated by any unit representing the magnitude of movement of the nut portion 24, such as the distance of movement of the nut portion 24.
  • the drug-solution administration device 10 may move the nut portion 24 at a faster speed than the movement speed of the nut portion 24 during the drug-solution administration operation.
  • the medicinal-solution administration device 10 can further shorten the time required to restart medicinal-solution administration.
  • control section 71 may move the nut section 24 from the detection position toward the distal end by the first movement amount. After that movement, the control unit 71 moves the nut part 24 by the second movement amount to the distal end side until the flow path in the medical-solution administration device 10 is filled with the medical solution, and then restarts the medical-solution administration.
  • the drive unit 40 may be controlled. In this manner, the medicinal-solution administration device 10 moves the nut part 24 toward the distal end by the first amount of movement, which is the amount of movement in the opposite direction when the medicinal-solution administration is interrupted, and then the flow path is filled with the medicinal solution. The nut portion 24 is moved distally until it is filled.
  • the medical-solution administration device 10 moves the nut portion 24 to a position suitable for the second priming, the medical-solution administration can be restarted in a short time.
  • the medicinal-solution administration device 10 moves the nut portion 24 at a faster speed than the movement speed of the nut portion 24 during the medicinal-solution administration operation. good too.
  • the medicinal-solution administration device 10 can further shorten the time required to restart medicinal-solution administration.
  • the driving section 40 may move the nut section 24 by transmitting driving force based on the rotation of the motor 44 .
  • the control unit 71 controls the detection position, the number of rotations of the motor 44 necessary for moving the nut portion 24 by the first amount of movement, and the number of revolutions of the motor 44 necessary for moving the nut portion 24 by the second amount of movement. and the remaining amount of the chemical solution may be estimated. Therefore, the medicinal-solution administration device 10 can estimate the remaining amount of the medicinal solution with high accuracy.
  • the medicinal-solution administration device 10 may include a plurality of position detection units 74a to 74d capable of detecting the nut portion 24 at different detection positions in the movable region of the nut portion 24.
  • the control unit 71 moves the nut portion 24 toward the distal end side until any one of the plurality of position detection units 74a to 74d detects the nut portion 24 in response to being able to resume the interrupted drug solution administration. can be moved in the opposite direction.
  • the medicinal-solution administration device 10 moves the nut portion 24 in the direction opposite to the tip (outlet port 28) side until any one of the plurality of position detection portions 74a to 74d detects. , it is possible to further shorten the time required to restart administration of the liquid medicine.
  • the medical-solution administration device 10 includes four position detectors 74a to 74d, but the number of position detectors 74 is arbitrary. When a plurality of position detectors 74 are provided, the intervals between adjacent position detectors 74 may be the same or different.
  • the medical-solution administration device 10 does not include a plurality of devices capable of detecting the nut portion 24 at a specific position as the position detection portion 74, but can detect the nut portion 24 at any position in the movable region of the nut portion 24. device may be provided.
  • the drug-solution administration device 10 may include a disposable cartridge 12 and a reusable device body 14 detachably attached to the cartridge 12 .
  • the reservoir 18, plunger 20, nut portion 24, drive portion 40, position detection portion 74, and control portion 71 may be provided in the cartridge 12 or the device main body 14, respectively.
  • the control unit 71 moves the nut portion 24 forward until the position detection unit 74 detects the nut portion 24 at the detection position. You may move it in the direction opposite to the side.
  • the control unit 71 may estimate the amount of liquid medicine remaining in the reservoir 18 based on the first movement amount, and control the driving unit 40 to restart administration of the liquid medicine based on the remaining amount.
  • the liquid medicine administration device 10 When the liquid medicine administration device 10 is composed of the cartridge 12 and the device main body 14 in this way, there is a possibility that the cartridge 12 and the device main body 14 are disconnected due to contact with an object during liquid medicine administration.
  • the medicinal-solution administration device 10 starts an operation for resuming medicinal-solution administration when the cartridge 12 and the device main body 14 are connected. It is possible to restart quickly. 3 and 4, the reservoir 18, the plunger 20, the nut portion 24, and the battery 42 are provided in the cartridge 12, and the drive portion 40, the position detection portion 74, and the control portion 71 are provided in the device main body 14. However, it is not limited to such a configuration.
  • the drug-solution administration device 10 may be made reusable, for example, with all components. good.
  • the medicinal solution administration device 10 may display the estimated remaining amount of medicinal solution on the display device. Therefore, the user can grasp the remaining amount of the liquid medicine by referring to the display device.
  • the medicinal-solution administration device 10 displays the remaining amount on the display of the output unit 95 of the remote controller 90.
  • the medicinal-solution administration device 10 itself has a display device, the remaining amount is displayed on the display device.
  • the medicinal-solution administration device 10 may notify and display the remaining amount of the medicinal solution on another device such as a smart phone, a smart watch, or a tablet, for example.

Abstract

A liquid drug administration device 10 comprises: a reservoir 18 into which a liquid drug is filled; a plunger 20 that is provided inside the reservoir 18 and can move in the longitudinal direction of the reservoir 18; a nut part 24 that can press the plunger 20 toward the tip end side of the reservoir 18 by moving within a motion region; a drive unit 40 that drives the nut part 24 so as to move within the motion region; a position detection unit 74 that detects the nut part 24 in a preset detection position in the motion region; and a control unit 71. The control unit 71 controls the drive unit 40 such that the nut part 24 is moved in the opposite direction from the tip end side until the position detection unit 74 detects the nut part 24 in the detection position, and such that the remaining amount of the liquid drug in the reservoir 18 is estimated on the basis of a first movement amount, which is the amount of movement in the opposite direction.

Description

薬液投与装置及びその制御方法、並びに、薬液投与システムMEDICINAL LIQUID ADMINISTRATION DEVICE, CONTROL METHOD THEREOF, AND MEDICINAL LIQUID ADMINISTRATION SYSTEM
 本開示は、薬液投与装置及びその制御方法、並びに、薬液投与システムに関する。 The present disclosure relates to a medical solution administration device, its control method, and a medical solution administration system.
 インスリン等の薬液を充填したカートリッジ(使い捨て部)を装置本体(リユース部)に取り付け、薬液に対してプランジャにより圧力を加えることで、薬液を患者の体内に投与する薬液投与装置が知られている。例えば、特許文献1には薬液投与装置に関する構成が記載されている。 2. Description of the Related Art There is known a drug solution administration device that administers a drug solution into a patient's body by attaching a cartridge (disposable part) filled with a drug solution such as insulin to a device body (reusable part) and applying pressure to the drug solution with a plunger. . For example, Patent Literature 1 describes a configuration related to a drug-solution administration device.
国際公開第2016/132936号WO2016/132936
 しかし、従来の構成においては、薬液の投与中にカートリッジ(使い捨て部)と装置本体(リユース部)との間の接続が誤って解除されるなどして薬液投与が中断した場合に、薬液投与の再開に要する時間を短縮する余地があった。 However, in the conventional configuration, if the connection between the cartridge (disposable part) and the device main body (reusable part) is erroneously disconnected during the administration of the liquid medicine, and the liquid medicine administration is interrupted, the liquid medicine administration cannot be performed. There was room for shortening the time required for reopening.
 本開示の目的は、薬液投与が中断した場合に、薬液投与の再開に要する時間を短縮することが可能な薬液投与装置及びその制御方法、並びに、薬液投与システムを提供することである。 An object of the present disclosure is to provide a drug-solution administration device, a control method thereof, and a drug-solution administration system capable of shortening the time required to restart drug-solution administration when the drug-solution administration is interrupted.
 本開示の一実施形態に係る薬液投与装置は、リザーバ内に充填した薬液をプランジャの押圧作用により生体内に投与する薬液投与装置であって、前記薬液が充填される前記リザーバと、前記リザーバ内に設けられ、前記リザーバの長手方向に移動可能な前記プランジャと、可動領域において移動することにより、前記プランジャを前記リザーバの先端側に押圧することが可能な可動部と、前記可動部を前記可動領域において移動させる駆動部と、前記可動領域の予め定められた検知位置において前記可動部を検知することが可能な検知部と、制御部と、を備え、前記制御部は、前記検知位置において前記検知部が前記可動部を検知するまで、前記可動部を前記先端側とは逆方向へ移動させ、当該逆方向への移動量である第1の移動量に基づき、前記リザーバにおける前記薬液の残存量を推定する。 A medical-solution administration device according to an embodiment of the present disclosure is a medical-solution administration device that administers a medical solution filled in a reservoir into a living body by a pressing action of a plunger, comprising: the reservoir filled with the medical solution; the plunger that is provided in the reservoir and is movable in the longitudinal direction of the reservoir; a movable portion that is capable of pressing the plunger toward the distal end side of the reservoir by moving in the movable region; a driving unit that moves in an area; a detection unit that can detect the movable unit at a predetermined detection position in the movable area; The movable part is moved in a direction opposite to the distal end side until the detection part detects the movable part, and based on a first movement amount, which is a movement amount in the opposite direction, the chemical solution remains in the reservoir. Estimate quantity.
 一実施形態として、前記制御部は、前記可動部を前記検知位置から前記第1の移動量だけ前記先端側へ移動させ、当該移動後、前記薬液投与装置における流路が前記薬液で充たされるまで、前記可動部を第2の移動量だけ前記先端側へ移動させた上で、前記薬液投与を再開するように、前記駆動部を制御する。 In one embodiment, the control section moves the movable section from the detection position to the distal end side by the first movement amount, and after the movement, until the flow path in the liquid medicine administration device is filled with the liquid medicine. and controlling the drive unit so as to move the movable unit toward the distal end by a second movement amount and then restart the administration of the liquid medicine.
 一実施形態として、前記駆動部は、モータの回転に基づく駆動力を伝達することにより、前記可動部を移動させ、前記制御部は、前記検知位置と、前記可動部が前記第1の移動量だけ移動するために必要な前記モータの回転数と、前記可動部が前記第2の移動量だけ移動するために必要な前記モータの回転数と、に基づき、前記薬液の残存量を推定する。 As one embodiment, the driving section moves the movable section by transmitting a driving force based on the rotation of a motor, and the control section controls the detection position and the movable section by the first movement amount. and the number of rotations of the motor required for moving the movable portion by the second movement amount.
 一実施形態として、それぞれ異なる前記検知位置において前記可動部を検知することが可能な複数の前記検知部を備え、前記制御部は、中断した薬液投与を再開することが可能になったことに応じて、前記複数の検知部のいずれかが前記可動部を検知するまで、前記可動部を前記先端側とは逆方向へ移動させる。 As one embodiment, a plurality of the detection units capable of detecting the movable portion at the detection positions different from each other are provided, and the control unit responds to resuming the interrupted drug solution administration. Then, the movable portion is moved in a direction opposite to the distal end side until any one of the plurality of detection portions detects the movable portion.
 一実施形態として、使い捨てのカートリッジと、前記カートリッジに着脱可能に設けられた再利用可能な装置本体と、を備え、前記リザーバ、前記プランジャ、前記可動部、前記駆動部、前記検知部、及び前記制御部は、それぞれ前記カートリッジ又は前記装置本体に設けられ、前記制御部は、薬液投与中に接続が解除された前記カートリッジ及び前記装置本体が再び接続されたことに応じて、前記検知位置において前記検知部が前記可動部を検知するまで、前記可動部を前記先端側とは逆方向へ移動させ、前記第1の移動量に基づき前記リザーバにおける前記薬液の残存量を推定し、当該残存量に基づき前記薬液投与を再開するように、前記駆動部を制御する。 As one embodiment, a disposable cartridge and a reusable device main body detachably provided on the cartridge are provided, and the reservoir, the plunger, the movable part, the driving part, the detection part, and the A control unit is provided in each of the cartridge and the device main body, and the control unit controls the detection position at the detection position in response to reconnection of the cartridge and the device main body that were disconnected during drug solution administration. The movable part is moved in a direction opposite to the distal end side until the detection part detects the movable part, the residual amount of the chemical solution in the reservoir is estimated based on the first movement amount, and the residual amount is Based on this, the driving unit is controlled so as to restart the administration of the liquid medicine.
 一実施形態として、推定された前記薬液の残存量を表示装置に表示させる。 As one embodiment, the estimated remaining amount of the chemical liquid is displayed on the display device.
 本開示の一実施形態に係る薬液投与システムは、上記薬液投与装置と、ユーザが前記薬液投与装置を操作するためのリモコンと、を備える。 A medical-solution administration system according to an embodiment of the present disclosure includes the medical-solution administration device described above and a remote control for a user to operate the medical-solution administration device.
 本開示の一実施形態に係る薬液投与装置の制御方法は、薬液が充填されるリザーバと、前記リザーバ内に設けられ、前記リザーバの長手方向に移動可能なプランジャと、可動領域において移動することにより、前記プランジャを前記リザーバの先端側に押圧することが可能な可動部と、前記可動部を前記可動領域において移動させる駆動部と、前記可動領域の予め定められた検知位置において前記可動部を検知することが可能な検知部と、制御部と、を備え、前記リザーバ内に充填した前記薬液を前記プランジャの押圧作用により生体内に投与する薬液投与装置の制御方法であって、前記制御部が、中断した薬液投与を再開することが可能になったことに応じて、前記検知位置において前記検知部が前記可動部を検知するまで、前記可動部を前記先端側とは逆方向へ移動させ、当該逆方向への移動量である第1の移動量に基づき、前記リザーバにおける前記薬液の残存量を推定する。 A control method for a drug-solution administration device according to an embodiment of the present disclosure includes a reservoir filled with a drug solution, a plunger provided in the reservoir and movable in the longitudinal direction of the reservoir, and a plunger moving in a movable region. a movable part capable of pressing the plunger toward the distal end of the reservoir; a driving part for moving the movable part in the movable area; and detecting the movable part at a predetermined detection position in the movable area. A control method for a drug-solution administration device for administering the drug solution filled in the reservoir into a living body by pressing action of the plunger, wherein moving the movable part in a direction opposite to the distal end side until the detection part detects the movable part at the detection position in response to being able to resume the interrupted drug solution administration; Based on the first moving amount, which is the moving amount in the opposite direction, the remaining amount of the chemical solution in the reservoir is estimated.
 本開示の一実施形態によれば、薬液投与が中断した場合に、薬液投与の再開に要する時間を短縮することが可能である。 According to one embodiment of the present disclosure, it is possible to shorten the time required to restart the administration of the medical solution when the administration of the medical solution is interrupted.
一実施形態に係る薬液投与システムの一例を示す図である。It is a figure which shows an example of the medical-solution administration system which concerns on one Embodiment. 図1の薬液投与装置の分解斜視図の一例を示す図である。It is a figure which shows an example of the exploded perspective view of the medical-solution administration apparatus of FIG. ナット部が非接触位置にある状態のカートリッジの一例を示す図である。FIG. 10 is a diagram showing an example of a cartridge in which the nut portion is in the non-contact position; ナット部が所定位置にある状態のカートリッジの一例を示す図である。FIG. 10 is a diagram showing an example of a cartridge with a nut portion in a predetermined position; 図1の薬液投与装置の制御に関する構成の一例を示すブロック図である。FIG. 2 is a block diagram showing an example of a configuration related to control of the drug-solution administration device of FIG. 1; 図1のリモコンのハードウェア構成の一例を示すブロック図である。FIG. 2 is a block diagram showing an example of the hardware configuration of the remote control shown in FIG. 1; FIG. 図1の薬液投与装置の動作手順を示すフローチャートである。2 is a flow chart showing an operation procedure of the drug-solution administration device of FIG. 1; 図1の薬液投与装置の動作手順を示すフローチャートである。2 is a flow chart showing an operation procedure of the drug-solution administration device of FIG. 1; 図1の薬液投与装置の動作手順を示すフローチャートである。2 is a flow chart showing an operation procedure of the drug-solution administration device of FIG. 1; 図1の薬液投与装置の動作手順を示すフローチャートである。2 is a flow chart showing an operation procedure of the drug-solution administration device of FIG. 1;
 以下、本開示の一実施形態について、図面を参照して説明する。各図面中、同一の構成又は機能を有する部分には、同一の符号を付している。本実施形態の説明において、同一の部分については、重複する説明を適宜省略又は簡略化する場合がある。 An embodiment of the present disclosure will be described below with reference to the drawings. In each drawing, parts having the same configuration or function are given the same reference numerals. In the description of the present embodiment, overlapping descriptions of the same parts may be appropriately omitted or simplified.
 (薬液投与システムの構成)
 図1は、一実施形態に係る薬液投与システム100の一例を示す図である。薬液投与システム100は、インスリン等の薬液を患者の生体内に投与する。薬液投与システム100は、薬液投与装置10及びリモコン90を備える。
(Structure of drug solution administration system)
FIG. 1 is a diagram showing an example of a drug-solution administration system 100 according to one embodiment. The drug solution administration system 100 administers a drug solution such as insulin into the patient's body. A drug-solution administration system 100 includes a drug-solution administration device 10 and a remote controller 90 .
 薬液投与装置10は、リザーバ内に充填した薬液をプランジャの押圧作用により生体内に持続的又は間欠的に投与する装置である。薬液投与装置10は、例えば、患者の腹部等に貼り付け可能(パッチ式)な携帯型の装置としてもよい。ただし、薬液投与装置10は、パッチ式に限定されず、チューブ式等であってもよい。 The drug solution administration device 10 is a device that continuously or intermittently administers the drug solution filled in the reservoir into the living body by the pressing action of the plunger. The drug-solution administration device 10 may be, for example, a portable device that can be attached to the patient's abdomen (patch type). However, the drug-solution administration device 10 is not limited to a patch type, and may be a tube type or the like.
 リモコン90は、患者等のユーザが薬液投与装置10を操作するための装置である。リモコン90は、薬液投与装置10から受け取った情報をユーザに通知したり、薬液投与装置10に対するユーザの操作を受け付けたりする。本実施形態では、リモコン90は薬液投与装置10に対応した専用の装置により実現されるが、スマートフォン又はタブレット等の汎用の情報処理装置により実現してもよい。また、本実施形態では、リモコン90がユーザへの情報通知及びユーザからの情報入力の受け付け等のユーザインタフェースを担う場合の例を説明するが、これに代えて、ユーザインタフェースの全部又は一部の機能を薬液投与装置10が備えるようにしてもよい。 The remote control 90 is a device for a user such as a patient to operate the drug-solution administration device 10 . The remote controller 90 notifies the user of information received from the medical-solution administration device 10 and accepts user's operations on the medical-solution administration device 10 . In this embodiment, the remote controller 90 is implemented by a dedicated device compatible with the drug-solution administration device 10, but may be implemented by a general-purpose information processing device such as a smart phone or a tablet. Further, in this embodiment, an example in which the remote controller 90 serves as a user interface such as notifying the user of information and receiving information input from the user will be described. The functions may be provided in the drug-solution administration device 10 .
 薬液投与装置10及びリモコン90は、無線通信回線、有線通信回線、又はこれらの組合せにより互いに通信可能に接続されている。以下、薬液投与装置10及びリモコン90がBluetooth(登録商標)により通信可能に接続されている例を説明する。 The medicinal-solution administration device 10 and the remote controller 90 are communicably connected to each other via a wireless communication line, a wired communication line, or a combination thereof. An example in which the drug-solution administration device 10 and the remote controller 90 are communicably connected by Bluetooth (registered trademark) will be described below.
 (薬液投与装置の構成)
 図2は、図1の薬液投与装置10の分解斜視図の一例を示す図である。図3は、ナット部24が非接触位置にある状態のカートリッジ12の一例を示す図である。図4は、ナット部24が所定位置にある状態のカートリッジ12の一例を示す図である。
(Structure of drug-solution administration device)
FIG. 2 is a diagram showing an example of an exploded perspective view of the drug-solution administration device 10 of FIG. FIG. 3 shows an example of the cartridge 12 with the nut portion 24 at the non-contact position. FIG. 4 shows an example of the cartridge 12 with the nut portion 24 at a predetermined position.
 図2に示すように、薬液投与装置10は、使い捨てのカートリッジ12、及び、再利用可能な装置本体14を備える。カートリッジ12は、片側が開口した平箱形状のベース部16を備えている。ベース部16は、平面視で略長方形状を有する。ベース部16は、患者の皮膚に貼着可能な図示しないクレードルに対して着脱可能に設けられてもよい。クレードルは、生体内に留置されるカニューレを含んでもよい。 As shown in FIG. 2, the drug-solution administration device 10 includes a disposable cartridge 12 and a reusable device main body 14. The cartridge 12 has a flat box-shaped base portion 16 which is open on one side. The base portion 16 has a substantially rectangular shape in plan view. The base portion 16 may be detachably provided to a cradle (not shown) that can be attached to the patient's skin. The cradle may include a cannula that is left in vivo.
 図2に示すように、ベース部16には、薬液が充填されるリザーバ18、リザーバ18内に設けられたプランジャ20、プランジャ20と同軸に配設された送りねじ軸22、及び、送りねじ軸22に螺合されたナット部(可動部)24が設けられる。ベース部16は、使い捨て部材として構成されている。 As shown in FIG. 2, the base portion 16 includes a reservoir 18 filled with a chemical solution, a plunger 20 provided in the reservoir 18, a feed screw shaft 22 coaxially arranged with the plunger 20, and a feed screw shaft. A nut portion (movable portion) 24 that is screwed onto 22 is provided. Base portion 16 is configured as a disposable member.
 リザーバ18は、ベース部16の長手方向に円筒状に延在している。リザーバ18の先端部は、外径及び内径が先端に向かって縮径している。このようなリザーバ18の先端部には、リザーバ18内へ薬液を導入するための導入ポート26、及び、リザーバ18内の薬液を導出するための導出ポート28(図3参照)が形成されている。導出ポート28には、リザーバ18内の薬液をカニューレに導く導出管29が連通している。 The reservoir 18 extends cylindrically in the longitudinal direction of the base portion 16 . The distal end portion of the reservoir 18 has an outer diameter and an inner diameter that decrease toward the distal end. An introduction port 26 for introducing the chemical solution into the reservoir 18 and an extraction port 28 (see FIG. 3) for extracting the chemical solution from the reservoir 18 are formed at the tip of the reservoir 18. . The lead-out port 28 communicates with a lead-out tube 29 that guides the drug solution in the reservoir 18 to the cannula.
 図3に示すように、プランジャ20は、樹脂材料等で一体的に成形されており、リザーバ18の軸線方向に沿って液密に摺動可能にリザーバ18内に設けられている。プランジャ20は、先端側を構成するプランジャ本体30、及び、プランジャ本体30に設けられて後端側を構成する押し子32を有している。プランジャ本体30のうち円筒状に形成された後端側には、シール部材34が装着されている。 As shown in FIG. 3, the plunger 20 is integrally formed of a resin material or the like, and is provided in the reservoir 18 so as to be liquid-tight and slidable along the axial direction of the reservoir 18 . The plunger 20 has a plunger main body 30 forming a tip side, and a pusher 32 provided on the plunger main body 30 and forming a rear end side. A seal member 34 is attached to the rear end side of the plunger main body 30 which is formed in a cylindrical shape.
 押し子32は、プランジャ本体30から後方に向かってリザーバ18の外側まで延出した一対の延出部36、及び、延出部36の後端部に設けられた一対の爪部38を備える。送りねじ軸22は、その一端部が軸受39によって軸支されており、ナット部24を移動させる駆動部40を構成する。 The pusher 32 has a pair of extensions 36 extending rearward from the plunger body 30 to the outside of the reservoir 18 and a pair of claws 38 provided at the rear ends of the extensions 36 . One end of the feed screw shaft 22 is rotatably supported by a bearing 39 and constitutes a drive section 40 that moves the nut section 24 .
 駆動部40は、動力源としての電池42、電池42によって駆動するモータ44、モータ44の回転駆動力を減速して伝達するギヤボックス(動力伝達機構)46、及び、ギヤボックス46の出力歯車48に噛み合う平歯車50が固定されて送りねじ軸22に一体回転可能に係止された伝達軸52をさらに有している。 The drive unit 40 includes a battery 42 as a power source, a motor 44 driven by the battery 42, a gearbox (power transmission mechanism) 46 that reduces the rotational driving force of the motor 44 and transmits it, and an output gear 48 of the gearbox 46. It further has a transmission shaft 52 to which a spur gear 50 meshing with is fixed and locked to the feed screw shaft 22 so as to be integrally rotatable.
 本実施形態では、電池42及び伝達軸52がカートリッジ12に設けられ、モータ44及びギヤボックス46が装置本体14に設けられている。このように、モータ44及びギヤボックス46を装置本体14に設けることにより、カートリッジ12のコストの削減を図ることができる。 In this embodiment, the battery 42 and transmission shaft 52 are provided in the cartridge 12, and the motor 44 and gear box 46 are provided in the device body 14. By thus providing the motor 44 and the gear box 46 in the apparatus main body 14, the cost of the cartridge 12 can be reduced.
 電池42には、カートリッジ12に装置本体14を接続した際に装置本体14のモータ44に電気的に接続する端子54が設けられている。伝達軸52は、送りねじ軸22と同軸に配設された状態でベース部16に設けられた一対の軸受56によって軸支されている。 The battery 42 is provided with a terminal 54 electrically connected to the motor 44 of the device body 14 when the device body 14 is connected to the cartridge 12 . The transmission shaft 52 is supported by a pair of bearings 56 provided on the base portion 16 while being coaxial with the feed screw shaft 22 .
 モータ44が回転すると、その回転力が送りねじ軸22へ伝えられ、送りねじ軸22の回転作用によりナット部24はプランジャ20へ向かう方向又はプランジャ20から離れる方向へ移動する。以下、ナット部24がプランジャ20へ向かう方向に移動するためのモータ44の回転を正回転と呼び、正回転と逆方向へのモータ44の回転を逆回転と呼ぶ。モータ44は正回転と逆回転の両方の回転をすることができるように構成されている。モータ44は、正回転又は逆回転に一定以上の力がかかった場合、回転駆動力がギヤボックス46以下の構成に伝わらないように構成される。モータ44として、例えば、ステッピングモータを採用してもよい。ステッピングモータを採用した場合、正回転又は逆回転に一定以上の力がかかったときは、モータ44は、入力パルスに同期しなくなるため回転駆動力を伝達しなくなる(脱調)。脱調によりナット部24が軸受56に接触している状態でモータ44が逆回転した場合であっても、モータ44、ギヤボックス46、伝達軸52等の機構に無理な力がかかって破損することを防ぐことができる。モータ44の出力軸には不図示のロータリーエンコーダが設けられ、モータ44が入力パルスに同期しなくなったこと(脱調)は、ロータリーエンコーダによりモータ44の回転を検出することで判定可能である。モータ44の動作状態は、ロータリーエンコーダ出力として制御部71へ伝達される。 When the motor 44 rotates, its rotational force is transmitted to the feed screw shaft 22 , and the rotation of the feed screw shaft 22 causes the nut portion 24 to move toward or away from the plunger 20 . Hereinafter, the rotation of the motor 44 for moving the nut portion 24 toward the plunger 20 will be referred to as forward rotation, and the rotation of the motor 44 in the direction opposite to the forward rotation will be referred to as reverse rotation. The motor 44 is configured to rotate both forward and reverse. The motor 44 is configured so that the rotational driving force is not transmitted to the components below the gear box 46 when a certain force or more is applied to the forward or reverse rotation. A stepping motor, for example, may be employed as the motor 44 . When a stepping motor is employed, when a certain amount of force is applied to forward or reverse rotation, the motor 44 will not be synchronized with the input pulse and will not transmit rotational driving force (step out). Even if the motor 44 rotates in the opposite direction while the nut portion 24 is in contact with the bearing 56 due to step-out, excessive force is applied to the mechanisms such as the motor 44, the gear box 46, and the transmission shaft 52, resulting in damage. can be prevented. A rotary encoder (not shown) is provided on the output shaft of the motor 44, and it is possible to determine whether the motor 44 is out of sync with the input pulse (step out) by detecting the rotation of the motor 44 with the rotary encoder. The operating state of the motor 44 is transmitted to the control section 71 as a rotary encoder output.
 ナット部24は、樹脂材料によって一体的に成形されており、略直方体形状に形成されたナット部本体58、及び、ナット部本体58に設けられたスライド部60を有している。ナット部本体58には、送りねじ軸22が螺合するねじ孔62、及び、ねじ孔62を両側から挟むようにして形成されて爪部38が挿通する一対の貫通孔64が形成されている。ナット部本体58の外面には、例えば、金属材料等で構成された補強カバー66が装着されている。 The nut portion 24 is integrally molded from a resin material and has a nut portion main body 58 formed in a substantially rectangular parallelepiped shape and a slide portion 60 provided on the nut portion main body 58 . The nut main body 58 is formed with a threaded hole 62 into which the feed screw shaft 22 is screwed, and a pair of through holes 64 which are formed to sandwich the threaded hole 62 from both sides and through which the claws 38 are inserted. A reinforcing cover 66 made of, for example, a metal material is attached to the outer surface of the nut body 58 .
 スライド部60は、ベース部16に設けられてプランジャ20の軸線方向に沿って延在した案内壁68に対してスライドする。すなわち、ナット部24は、使用前の状態において、プランジャ20に接触しない非接触位置にあり(図3参照)、送りねじ軸22の回転作用下に非接触位置から移動し、プランジャ20に係止してプランジャ20を先端側に押圧する(図4参照)。 The slide portion 60 slides on a guide wall 68 provided on the base portion 16 and extending along the axial direction of the plunger 20 . That is, the nut portion 24 is in a non-contact position (see FIG. 3) where it does not contact the plunger 20 before use. Then, the plunger 20 is pushed forward (see FIG. 4).
 図2~図4に示すように、装置本体14は、ベース部16の開口を閉塞するようにしてベース部16に着脱可能に設けられた蓋体70、並びに、制御部71、記憶部72、通信部73、位置検知部74、及び、姿勢検知部75を備えている。制御部71には、モータ44、記憶部72、通信部73、位置検知部74、及び姿勢検知部75がバス79を介して電気的に接続されている(図5参照)。制御部71は、薬液投与装置10の各部を制御して、薬液投与装置10の動作に関わる処理を実行する。例えば、制御部71は、リモコン90から送信された薬液投与に関する情報に基づいてモータ44を駆動制御する。 As shown in FIGS. 2 to 4, the apparatus main body 14 includes a lid body 70 detachably provided on the base portion 16 so as to close the opening of the base portion 16, a control portion 71, a storage portion 72, A communication unit 73 , a position detection unit 74 , and an orientation detection unit 75 are provided. The motor 44, storage unit 72, communication unit 73, position detection unit 74, and orientation detection unit 75 are electrically connected to the control unit 71 via a bus 79 (see FIG. 5). The control unit 71 controls each part of the medicinal-solution administration device 10 and executes processing related to the operation of the medicinal-solution administration device 10 . For example, the control unit 71 drives and controls the motor 44 based on information regarding drug solution administration transmitted from the remote controller 90 .
 位置検知部(検知部)74は、プランジャ20の軸線方向におけるナット部24の位置を検知するセンサである。位置検知部74は、例えば、案内壁68においてスライド部60が存在する位置を検出することで、ナット部24の位置を検知してもよい。具体的には、位置検知部74は、案内壁68に沿って間隔を置いて設けられ、それぞれ対応する検知位置においてナット部24を検知することが可能な、複数の位置検知部74a~74dにより構成してもよい。複数の位置検知部74a~74dの各々は、例えば、接触センサにより実現してもよい。この場合、位置検知部74は、複数の接触センサのいずれかがスライド部60の接触を検出したことに基づき、その接触センサに対応するナット部24の位置を検知することが可能である。このように、位置検知部74を複数の位置検知部74a~74dとして構成することにより、プランジャ20の軸線方向におけるナット部24の位置を容易に検出することができる。位置検知部74の構成は、ナット部24の位置を検知可能であれば、接触センサによる構成に限られない。例えば、磁石等の磁界発生源とホール素子を組み合わせた磁界検出、あるいは、LED等の光源と受光素子を組み合わせた光検出等を用いた、非接触センサによる構成でもよい。以降の実施形態においては、スライド部60の位置検出とナット部24の位置検知を同義とする。 The position detection portion (detection portion) 74 is a sensor that detects the position of the nut portion 24 in the axial direction of the plunger 20 . The position detection section 74 may detect the position of the nut section 24 by detecting the position of the slide section 60 on the guide wall 68, for example. Specifically, the position detection part 74 is provided at intervals along the guide wall 68, and is capable of detecting the nut part 24 at each corresponding detection position. may be configured. Each of the plurality of position detection units 74a to 74d may be realized by contact sensors, for example. In this case, the position detection section 74 can detect the position of the nut section 24 corresponding to one of the plurality of contact sensors based on detection of the contact of the slide section 60 . By configuring the position detection portion 74 as a plurality of position detection portions 74a to 74d in this manner, the position of the nut portion 24 in the axial direction of the plunger 20 can be easily detected. The configuration of the position detection portion 74 is not limited to a contact sensor configuration as long as the position of the nut portion 24 can be detected. For example, a configuration using a non-contact sensor using magnetic field detection combining a magnetic field generation source such as a magnet and a Hall element, or light detection combining a light source such as an LED and a light receiving element, or the like may be used. In the following embodiments, position detection of the slide portion 60 and position detection of the nut portion 24 are synonymous.
 図5は、図1の薬液投与装置10の制御に関する構成の一例を示すブロック図である。前述のように、制御部71には、モータ44、記憶部72、通信部73、位置検知部74、及び姿勢検知部75がバス79を介して電気的に接続されている。 FIG. 5 is a block diagram showing an example of a configuration related to control of the medicinal-solution administration device 10 of FIG. As described above, the motor 44 , the storage unit 72 , the communication unit 73 , the position detection unit 74 , and the orientation detection unit 75 are electrically connected to the control unit 71 via the bus 79 .
 制御部71は、1つ以上のプロセッサである。制御部71は、薬液投与装置10を構成する各構成部と通信可能に接続され、薬液投与装置10全体の動作を制御する。プロセッサは、CPU(Central Processing Unit)等の汎用プロセッサ、又は特定の処理に特化した専用プロセッサである。制御部71には、1つ以上の専用回路が含まれてもよいし、又は制御部71において、1つ以上のプロセッサを1つ以上の専用回路に置き換えてもよい。専用回路は、例えば、FPGA(Field Programmable Gate Array)である。 The control unit 71 is one or more processors. The control unit 71 is communicably connected to each component constituting the drug-solution administration device 10 and controls the operation of the drug-solution administration device 10 as a whole. The processor is a general-purpose processor such as a CPU (Central Processing Unit) or a dedicated processor specialized for specific processing. The controller 71 may include one or more dedicated circuits, or one or more processors may be replaced with one or more dedicated circuits in the controller 71 . The dedicated circuit is, for example, an FPGA (Field Programmable Gate Array).
 記憶部72は、1つ以上の半導体メモリ、1つ以上の磁気メモリ、1つ以上の光メモリ、又はこれらのうち少なくとも2種類の組み合わせである。半導体メモリは、例えば、RAM(Random Access Memory)又はROM(Read Only Memory)である。記憶部72は、例えば、主記憶装置、補助記憶装置、又はキャッシュメモリとして機能する。例えば、記憶部72は、制御部71からの情報を記憶してもよい。また、記憶部72に記憶された情報は、制御部71の制御により、通信部73を介してリモコン90へ送信されてもよい。 The storage unit 72 is one or more semiconductor memories, one or more magnetic memories, one or more optical memories, or a combination of at least two of them. The semiconductor memory is, for example, RAM (Random Access Memory) or ROM (Read Only Memory). The storage unit 72 functions as, for example, a main memory device, an auxiliary memory device, or a cache memory. For example, the storage section 72 may store information from the control section 71 . Information stored in storage unit 72 may be transmitted to remote controller 90 via communication unit 73 under the control of control unit 71 .
 通信部73は、リモコン90と通信するための通信インタフェースである。本実施形態では、通信部73はBluetooth(登録商標)によりリモコン90と通信するが、これに限られず、例えば、無線LAN(Local Area Network)等の他の無線通信経路又は有線ケーブルを介して通信してもよい。 The communication unit 73 is a communication interface for communicating with the remote control 90. In this embodiment, the communication unit 73 communicates with the remote controller 90 via Bluetooth (registered trademark), but is not limited to this, and communicates via other wireless communication paths such as a wireless LAN (Local Area Network) or a wired cable, for example. You may
 薬液投与装置10に、薬液投与装置10の姿勢を検知する装置である姿勢検知部75を設けてもよい。姿勢検知部75は、三軸加速度センサ又はジャイロセンサ等により実現されてもよい。 The medicinal-solution administration device 10 may be provided with a posture detection unit 75 that is a device for detecting the posture of the medicinal-solution administration device 10 . The orientation detection unit 75 may be realized by a triaxial acceleration sensor, a gyro sensor, or the like.
 薬液投与装置10の制御は、プログラムを、制御部71に含まれるプロセッサで実行することにより実行されてもよい。すなわち、薬液投与装置10の制御は、ソフトウェアにより実現されてもよい。この場合、プログラムは、薬液投与装置10の動作に含まれるステップの処理をコンピュータに実行させることで、そのステップの処理に対応する機能をコンピュータに実現させる。あるいは、薬液投与装置10の一部又は全ての機能が、制御部71に含まれる専用回路により実現されてもよい。すなわち、薬液投与装置10の一部又は全ての機能が、ハードウェアにより実現されてもよい。
 (リモコンの構成)
 図6は、図1のリモコン90のハードウェア構成の一例を示すブロック図である。リモコン90は、制御部91、記憶部92、通信部93、入力部94、出力部95、及びバス99を備える。
Control of the medicinal-solution administration device 10 may be executed by executing a program by a processor included in the control unit 71 . That is, the control of the drug-solution administration device 10 may be realized by software. In this case, the program causes the computer to execute the processing of steps included in the operation of the drug-solution administration device 10, thereby causing the computer to implement the functions corresponding to the processing of the steps. Alternatively, part or all of the functions of the medicinal-solution administration device 10 may be implemented by a dedicated circuit included in the control section 71 . That is, part or all of the functions of the drug-solution administration device 10 may be realized by hardware.
(Remote control configuration)
FIG. 6 is a block diagram showing an example of the hardware configuration of the remote control 90 of FIG. 1. As shown in FIG. The remote controller 90 includes a control section 91 , a storage section 92 , a communication section 93 , an input section 94 , an output section 95 and a bus 99 .
 制御部91は、1つ以上のプロセッサである。制御部91は、リモコン90を構成する各構成部とバス99を介して通信可能に接続され、リモコン90全体の動作を制御する。プロセッサは、CPU若しくはGPU(Graphics Processing Unit)等の汎用プロセッサ、又は特定の処理に特化した専用プロセッサである。制御部91には、1つ以上の専用回路が含まれてもよいし、又は制御部91において、1つ以上のプロセッサを1つ以上の専用回路に置き換えてもよい。専用回路は、例えば、FPGAである。 The control unit 91 is one or more processors. The control unit 91 is communicably connected to each constituent unit of the remote controller 90 via a bus 99 and controls the operation of the remote controller 90 as a whole. The processor is a general-purpose processor such as a CPU or GPU (Graphics Processing Unit), or a dedicated processor specialized for specific processing. Control unit 91 may include one or more dedicated circuits, or one or more processors may be replaced by one or more dedicated circuits in control unit 91 . A dedicated circuit is, for example, an FPGA.
 記憶部92は、1つ以上の半導体メモリ、1つ以上の磁気メモリ、1つ以上の光メモリ、又はこれらのうち少なくとも2種類の組み合わせである。半導体メモリは、例えば、RAM又はROMである。RAMは、例えば、SRAM(Static RAM)又はDRAM(Dynamic RAM)である。ROMは、例えば、EEPROM(Electrically Erasable Programmable ROM)である。記憶部92は、例えば、主記憶装置、補助記憶装置、又はキャッシュメモリとして機能する。 The storage unit 92 is one or more semiconductor memories, one or more magnetic memories, one or more optical memories, or a combination of at least two of them. A semiconductor memory is, for example, a RAM or a ROM. RAM is, for example, SRAM (Static RAM) or DRAM (Dynamic RAM). The ROM is, for example, an EEPROM (Electrically Erasable Programmable ROM). The storage unit 92 functions, for example, as a main storage device, an auxiliary storage device, or a cache memory.
 通信部93は、薬液投与装置10と通信するための通信インタフェースである。通信部93は、薬液投与装置10と通信して、ユーザにより入力された情報を薬液投与装置10へ送信したり、薬液投与装置10から情報を受信したりする。通信部93は例えばBluetooth(登録商標)により薬液投与装置10と通信するが、これに限られず、例えば、無線LAN等の他の無線通信経路又は有線ケーブルにより通信してもよい。 The communication unit 93 is a communication interface for communicating with the drug-solution administration device 10. The communication unit 93 communicates with the medicinal-solution administration device 10 to transmit information input by the user to the medicinal-solution administration device 10 and receive information from the medicinal-solution administration device 10 . The communication unit 93 communicates with the medicinal-solution administration device 10 via, for example, Bluetooth (registered trademark), but is not limited to this, and may communicate via other wireless communication paths such as wireless LAN or wired cables, for example.
 入力部94は、ユーザの入力操作を受け付けて、ユーザの操作に基づく入力情報を取得する1つ以上の入力インタフェースを含む。入力部94は、例えば、出力部95のディスプレイ(表示装置)と一体的に設けられたタッチスクリーンであるが、これに限らず、物理キー(例えば、外付けテンキー)、静電容量キー、ポインティングディバイス、又は音声入力を受け付けるマイク等としてもよい。 The input unit 94 includes one or more input interfaces that receive user's input operations and acquire input information based on the user's operations. The input unit 94 is, for example, a touch screen provided integrally with the display (display device) of the output unit 95, but is not limited to this, physical keys (eg, external numeric keypad), capacitance keys, pointing It may be a device or a microphone or the like that receives voice input.
 表示部としての出力部95は、ユーザに対して情報を出力し、ユーザに通知する1つ以上の出力インタフェースを含む。例えば、出力部95は、情報を画像表示により出力するディスプレイ、LED(Light Emitting Diode)、スピーカ、又はバイブレータ等であるが、これらに限定されない。 The output unit 95 as a display unit outputs information to the user and includes one or more output interfaces for notifying the user. For example, the output unit 95 is a display that outputs information by image display, an LED (Light Emitting Diode), a speaker, a vibrator, or the like, but is not limited to these.
 リモコン90の機能は、本実施形態に係るプログラムを、制御部91に含まれるプロセッサで実行することにより実現されてもよい。すなわち、リモコン90の機能は、ソフトウェアにより実現されてもよい。この場合、プログラムは、リモコン90の動作に含まれるステップの処理をコンピュータに実行させることで、そのステップの処理に対応する機能をコンピュータに実現させる。あるいは、リモコン90の一部又は全ての機能が、制御部91に含まれる専用回路により実現されてもよい。すなわち、リモコン90の一部又は全ての機能が、ハードウェアにより実現されてもよい。 The functions of the remote control 90 may be realized by executing the program according to the present embodiment with a processor included in the control unit 91. That is, the functions of the remote control 90 may be realized by software. In this case, the program causes the computer to execute the processing of steps included in the operation of the remote control 90, thereby causing the computer to implement the functions corresponding to the processing of the steps. Alternatively, some or all of the functions of remote controller 90 may be realized by a dedicated circuit included in control section 91 . That is, some or all of the functions of remote control 90 may be realized by hardware.
 (薬液投与装置の動作)
 本実施形態に係る薬液投与装置10を作動させる場合、まず、ユーザは、包装容器からカートリッジ12を取り出す。この状態で、カートリッジ12のリザーバ18内に薬液は充填されておらず、ナット部24はプランジャ20に接触しない非接触位置にある(図3参照)。
(Operation of chemical-solution administration device)
When operating the drug-solution administration device 10 according to this embodiment, first, the user takes out the cartridge 12 from the packaging container. In this state, the reservoir 18 of the cartridge 12 is not filled with the chemical solution, and the nut portion 24 is in the non-contact position where it does not contact the plunger 20 (see FIG. 3).
 次いで、ユーザは、リザーバ18に対するプランジャ20の位置を調節し、薬液が密閉保存されているバイアル等の薬液容器からリザーバ18内に任意の量の薬液を導入ポート26から充填する。その後、ユーザは、装置本体14をカートリッジ12に接続(初回接続)する。これにより、カートリッジ12の電池42の電力が装置本体14の構成部品に供給され、装置本体14のギヤボックス46の出力歯車48がカートリッジ12の平歯車50に噛み合う。制御部71、記憶部72等は、この電池42の電力の供給を受けて起動する。 Next, the user adjusts the position of the plunger 20 with respect to the reservoir 18 and fills the reservoir 18 with an arbitrary amount of drug solution from the introduction port 26 from a drug solution container such as a vial in which the drug solution is hermetically stored. After that, the user connects the device main body 14 to the cartridge 12 (initial connection). As a result, the power of the battery 42 of the cartridge 12 is supplied to the components of the device main body 14 , and the output gear 48 of the gear box 46 of the device main body 14 meshes with the spur gear 50 of the cartridge 12 . The control unit 71, the storage unit 72, and the like are activated by being supplied with power from the battery 42. FIG.
 続いて、ユーザは、薬液投与装置10の第1のプライミングを行う。第1のプライミングとは、包装容器から取り出したカートリッジ12に薬液を充填し、カートリッジ12と装置本体14を接続した直後の薬液投与装置10に対して行う操作で、薬液投与装置10のナット部24をプランジャ20に係止させるとともに、流路を薬液で充たす操作をいう。具体的には、リモコン90を操作してモータ44を正回転に回転駆動させる。これにより、モータ44の回転駆動力がギヤボックス46、平歯車50、及び、伝達軸52を介して送りねじ軸22に伝達されるため、送りねじ軸22が回転し、ナット部24が案内壁68をスライドしながらプランジャ20側に進行する。 Subsequently, the user performs the first priming of the medicinal-solution administration device 10 . The first priming is an operation performed on the drug solution administration device 10 immediately after the cartridge 12 taken out of the packaging container is filled with the drug solution and the cartridge 12 and the device main body 14 are connected. is engaged with the plunger 20 and the flow channel is filled with the chemical solution. Specifically, the remote controller 90 is operated to rotate the motor 44 forward. As a result, the rotational driving force of the motor 44 is transmitted to the feed screw shaft 22 via the gear box 46, the spur gear 50, and the transmission shaft 52, so that the feed screw shaft 22 rotates, and the nut portion 24 moves toward the guide wall. While sliding 68, it advances to the plunger 20 side.
 ナット部24がプランジャ20の先端側に進行すると、一対の爪部38がナット部24の貫通孔64を構成する壁面に当たり、一対の延出部36が互いに近接するように撓む。そして、爪部38が貫通孔64を通り抜けると、延出部36は撓んだ状態から元の状態に復帰し、ナット部24がプランジャ20の後端部に対して係止される。これにより、ナット部24は、プランジャ20を先端側に押圧可能となる。その後、さらに、ナット部24を進行させることにより、リザーバ18内の薬液がプランジャ20に押圧され、導出管29の内孔が薬液で満たされて第1のプライミングが完了する。この第1のプライミングは、導出管29に流体的に接続して薬液投与装置10の外部へ露出する接続針管から薬液が排出されることをユーザが視認することで完了する。第1のプライミング完了時において、ナット部24がプランジャ20に対して係止された位置は、薬液の初期充填量に対応する。 When the nut portion 24 advances toward the distal end side of the plunger 20, the pair of claw portions 38 hits the wall surface forming the through hole 64 of the nut portion 24, and the pair of extension portions 36 are bent so as to approach each other. When the claw portion 38 passes through the through hole 64 , the extension portion 36 returns from the bent state to its original state, and the nut portion 24 is locked to the rear end portion of the plunger 20 . Thereby, the nut portion 24 can press the plunger 20 toward the distal end side. Thereafter, by advancing the nut portion 24 further, the chemical solution in the reservoir 18 is pressed against the plunger 20, and the inner hole of the lead-out tube 29 is filled with the chemical solution, completing the first priming. This first priming is completed when the user visually recognizes that the drug solution is discharged from the connecting needle tube that is fluidly connected to the outlet tube 29 and exposed to the outside of the drug solution administration device 10 . At the completion of the first priming, the position where the nut portion 24 is locked with respect to the plunger 20 corresponds to the initial filling amount of the chemical solution.
 続いて、ユーザは、図示しないクレードルを皮膚の所定位置に貼着する。そして、ユーザは、穿刺機構を用いて、クレードルの開口を通じてカニューレを生体内に留置させる。次いで、ユーザが、カートリッジ12と装置本体14を接続させた薬液投与装置10をクレードルに装着することで接続針管とカニューレが連通する。この状態で制御部71がモータ44を回転制御することにより、リザーバ18内の薬液が生体内に持続的又は間欠的に投与されることとなる。制御部71は、リモコン90から指示された薬液投与のスケジュールに従ってモータ44の回転を制御し、患者の容体に合わせて基礎レート又はボーラス等の様々なレートで薬液を投与する。基礎レートとは、基礎分泌に当たる単位時間当たりの薬液量である。ボーラスとは、食事又は血糖値の上昇に対する追加分泌に当たる薬液量である。 Subsequently, the user attaches a cradle (not shown) to a predetermined position on the skin. Then, the user uses the puncture mechanism to leave the cannula in the living body through the opening of the cradle. Next, the user attaches the drug solution administration device 10, in which the cartridge 12 and the device main body 14 are connected, to the cradle, so that the connecting needle tube and the cannula communicate with each other. By controlling the rotation of the motor 44 by the control unit 71 in this state, the drug solution in the reservoir 18 is continuously or intermittently administered into the living body. The control unit 71 controls the rotation of the motor 44 in accordance with the drug solution administration schedule instructed from the remote controller 90, and administers the drug solution at various rates such as a basal rate or a bolus according to the patient's condition. The basal rate is the amount of drug solution per unit time corresponding to basal secretion. A bolus is the amount of drug solution that provides additional secretion in response to a meal or an increase in blood sugar level.
 カートリッジ12のリザーバ18に充填された薬液は、例えば、数日間~1週間をかけて生体内に投与され、投与期間が経過すると、カートリッジ12は交換される。カートリッジ12の交換の都度、カートリッジ12のリザーバ18への薬液充填、カートリッジ12と装置本体14との接続、及び、第1のプライミングが行われる。このような操作を経て、薬液を投与している間、薬液投与装置10は、例えば、第1のプライミング完了時におけるナット部24がプランジャ20に係止された位置を基準として、ユーザの送液指示に基づき実行された送液動作に伴うモータ44の回転数に基づき、投与済薬液量(推定投与量ともいう)又は薬液の残存量を推定することができる。 The drug solution filled in the reservoir 18 of the cartridge 12 is administered into the body over, for example, several days to one week, and the cartridge 12 is replaced after the administration period has passed. Each time the cartridge 12 is replaced, filling of the reservoir 18 of the cartridge 12 with the chemical solution, connection of the cartridge 12 and the apparatus main body 14, and first priming are performed. Through such an operation, while the medicinal solution is being administered, the medicinal-solution administration device 10, for example, uses the position where the nut part 24 is locked by the plunger 20 at the time of completion of the first priming as a reference. Based on the number of revolutions of the motor 44 associated with the liquid feeding operation executed based on the instruction, the amount of the administered liquid medicine (also referred to as an estimated dose amount) or the remaining amount of the liquid medicine can be estimated.
 本実施形態に係る薬液投与装置10の投与履歴は、薬液投与装置10の誤使用や投与履歴データの取り違えを防ぐ観点から、リモコン90により管理されてもよい。また、装置本体14の記憶部72は、電力供給が中断すると消去される構成としてもよい。これにより、装置本体14の制御部71や記憶部72が、複数のカートリッジを個別のID等で識別することなく、保持するデータ量を削減したりできるため、薬液投与装置10のコストを抑えることができる。 The administration history of the medicinal-solution administration device 10 according to this embodiment may be managed by the remote controller 90 from the viewpoint of preventing misuse of the medicinal-solution administration device 10 and mistaken administration history data. Further, the storage unit 72 of the device body 14 may be configured to be erased when the power supply is interrupted. As a result, the control unit 71 and the storage unit 72 of the device main body 14 can reduce the amount of data to be held without identifying a plurality of cartridges by individual IDs or the like, so that the cost of the drug-solution administration device 10 can be reduced. can be done.
 しかしながら、薬液投与装置10が薬液を投与している間に、意図せず薬液投与動作が中断することがありうる。例えば、薬液投与装置10が患者の腹部等に装着された状態で別の物体に衝突するなどして、薬液投与中にカートリッジ12と装置本体14との間の接続が解除されると、制御部71、記憶部72等への電力供給が中断し、薬液投与装置10は動作を停止する。このとき、リモコン90へ未送信状態で記憶部72に記憶されていた投与履歴がリセットされてしまう。このため、ユーザが再び装置本体14をカートリッジ12に接続して投与を再開しても、第1のプライミング完了時のナット部24の位置に基づく初期充填量情報や、推定投与量または薬液の残存量情報等が消失しているため、薬液投与装置10は、残存量に基づくカートリッジ12の交換タイミングを正確に知ることができない。 However, while the medical solution administration device 10 is administering the medical solution, the medical solution administration operation may be unintentionally interrupted. For example, when the drug solution administration device 10 collides with another object while being attached to the patient's abdomen, etc., and the connection between the cartridge 12 and the device main body 14 is released during drug solution administration, the control unit 71, storage unit 72, etc., and the drug-solution administration device 10 stops operating. At this time, the administration history stored in the storage unit 72 without being transmitted to the remote controller 90 is reset. Therefore, even if the user reconnects the apparatus main body 14 to the cartridge 12 and resumes administration, the initial filling amount information based on the position of the nut portion 24 at the time of completion of the first priming, the estimated amount of administration, or the residual amount of the liquid medicine can be obtained. Since the amount information and the like are lost, the medical-solution administration device 10 cannot accurately know the replacement timing of the cartridge 12 based on the remaining amount.
 このように、薬液投与が中断した場合であってもカートリッジ12の交換タイミングを正確に検出するには、再度、プランジャ20の位置、あるいは薬液の残存量を把握することが必要になる。一方で、記憶部72等にプランジャ20等の位置情報を残す構成にしたとしても、カートリッジ12と装置本体14との接続解除中に、ユーザがプランジャ20に接触するなどして、プランジャ20が移動し、記憶部72等の情報と整合しなくなる場合もありうる。このような場合、薬液投与装置は、プランジャ20の位置を把握するために、ナット部24を初期位置である軸受56に接触させた後に、接続針管から薬液が排出されるまでナット部24を薬液排出方向に移動させることも可能である。また、薬液投与装置は、スライド部60を案内壁68の端部まで移動させたときの位置を初期位置としてもよい。この場合、案内壁68の端部には、スライド部60がそれ以上移動できないように規制部が設けられてよい。いずれの場合も、薬液投与装置は、モータ44が脱調したかどうかによって、ナット部24が初期位置に達したかどうかを検知することができる。しかしながら、リザーバ18に残っている薬液が少ない場合、モータ44の駆動によって、プランジャ20及びナット部24を初期位置と薬液投与中断時の位置との間で移動させる際に時間がかかる場合がある。このため、従来の構成においては、薬液投与が中断後から再開までに時間がかかる場合があった。 Thus, in order to accurately detect the replacement timing of the cartridge 12 even when the administration of the liquid medicine is interrupted, it is necessary to grasp the position of the plunger 20 or the remaining amount of the liquid medicine again. On the other hand, even if the positional information of the plunger 20 and the like is left in the storage unit 72 and the like, the plunger 20 may move when the user touches the plunger 20 while the cartridge 12 and the apparatus main body 14 are disconnected. However, there may be a case where the information does not match the information in the storage unit 72 or the like. In such a case, in order to grasp the position of the plunger 20, the medicinal-solution administration device brings the nut portion 24 into contact with the bearing 56, which is the initial position, and then moves the nut portion 24 until the medicinal solution is discharged from the connecting needle tube. It is also possible to move in the ejection direction. In addition, the drug-solution administration device may be set to the initial position when the slide portion 60 is moved to the end portion of the guide wall 68 . In this case, a restricting portion may be provided at the end of the guide wall 68 so that the sliding portion 60 cannot move any further. In either case, the medicinal-solution administration device can detect whether or not the nut portion 24 has reached the initial position based on whether or not the motor 44 has stepped out. However, when the amount of liquid medicine remaining in the reservoir 18 is small, it may take time to move the plunger 20 and the nut portion 24 between the initial positions and the positions at which the liquid medicine administration is interrupted by driving the motor 44 . For this reason, in the conventional configuration, it sometimes takes a long time to restart the drug solution administration after the interruption.
 本実施形態に係る薬液投与装置10は、ナット部24の初期位置よりも薬液排出方向側において、ナット部24の位置を検知する位置検知部74を備える。薬液投与装置10は、カートリッジ12と装置本体14とが再接続されると、第2のプライミングを実施する。第2のプライミングとは、カートリッジ12と装置本体14とが再接続された直後の薬液投与装置10のナット部24の位置を検知するとともに、流路を薬液で充たす操作をいう。具体的には、薬液投与装置10は、位置検知部74によりナット部24の位置が検知可能になるまでモータ44を通常よりも速く逆回転させて、ナット部24を後退させる。位置検知部74がナット部24の位置を検知すると、薬液投与装置10は、逆回転させた回転数と同じ回転数だけモータ44を通常よりも速く正回転させてナット部24を押し進め、その位置から接続針管から薬液が排出されるまでナット部24を前進させる。このように、薬液投与装置10は、カートリッジ12と装置本体14とが再接続された場合に、ナット部24を初期位置まで戻すのではなく、位置を検知可能になるまで後退させ、その検知された位置から接続針管から薬液が排出されるまで前進させる。よって、薬液投与装置10によれば、薬液投与の再開に要する時間を短縮することが可能である。 The medicinal-solution administration device 10 according to the present embodiment includes a position detection portion 74 that detects the position of the nut portion 24 on the side of the medicinal-solution discharge direction relative to the initial position of the nut portion 24 . The medical-solution administration device 10 performs the second priming when the cartridge 12 and the device main body 14 are reconnected. The second priming refers to an operation of detecting the position of the nut portion 24 of the drug solution administration device 10 immediately after the cartridge 12 and the device main body 14 are reconnected, and filling the channel with the drug solution. Specifically, the medical-solution administration device 10 causes the motor 44 to reversely rotate faster than usual until the position of the nut portion 24 can be detected by the position detection portion 74 to retract the nut portion 24 . When the position detection unit 74 detects the position of the nut part 24, the drug-solution administration device 10 rotates the motor 44 forward faster than usual by the same number of rotations as the number of rotations of the reverse rotation to push the nut part 24 forward. , the nut portion 24 is advanced until the drug solution is discharged from the connecting needle tube. In this manner, when the cartridge 12 and the device main body 14 are reconnected, the drug-solution administration device 10 does not return the nut portion 24 to the initial position, but retreats until the position can be detected. advance until the medicinal solution is discharged from the connected needle tube. Therefore, according to the medicinal-solution administration device 10, it is possible to shorten the time required to restart the medicinal-solution administration.
 図7~図10は、図1の薬液投与装置10の動作手順を示すフローチャートである。図7~図10を参照して説明する薬液投与装置10の動作は薬液投与装置10の制御方法の一つに相当し得る。図7~図10の各ステップの動作は、薬液投与装置10の制御部71又はリモコン90の制御部91による制御に基づき実行され得る。以下の処理は、薬液投与装置10の装置本体14とカートリッジ12との間の接続が解除された後に、再度、接続が検出されたことに応じて実行される。カートリッジ12は、初回接続時には、ナット部24は非接触位置にあり、モータ44は、逆回転により直ちに初期位置で脱調する。一方、再接続時には、第1のプライミング及び薬液投与により、ナット部24は初期位置から離れた位置に移動し、モータ44は、逆回転しても直ちに脱調しない。したがって、薬液投与装置10の制御部71は、装置本体14とカートリッジ12とが接続され、電池42から電力が供給されたことに応じて起動するプログラムにおいて、モータ44の逆回転による脱調の有無によって、装置本体14とカートリッジ12との間の接続が初回接続による接続なのか、あるいは、再接続による接続なのかを判定することができる。 7 to 10 are flowcharts showing the operation procedure of the medicinal-solution administration device 10 of FIG. The operation of the medical-solution administration device 10 described with reference to FIGS. 7 to 10 can correspond to one control method of the medical-solution administration device 10. FIG. 7 to 10 can be executed under the control of the control unit 71 of the drug-solution administration device 10 or the control unit 91 of the remote controller 90. FIG. The following processing is executed in response to detection of connection again after the connection between the device main body 14 of the drug-solution administration device 10 and the cartridge 12 has been released. When the cartridge 12 is connected for the first time, the nut portion 24 is at the non-contact position, and the motor 44 is immediately out of step at the initial position due to the reverse rotation. On the other hand, at the time of reconnection, the nut part 24 is moved to a position away from the initial position by the first priming and chemical solution administration, and the motor 44 does not immediately lose synchronism even if it rotates in the reverse direction. Therefore, the control unit 71 of the medicinal-solution administration device 10 determines whether or not step-out due to the reverse rotation of the motor 44 occurs in a program that is activated when the device main body 14 and the cartridge 12 are connected and power is supplied from the battery 42 . , it is possible to determine whether the connection between the apparatus main body 14 and the cartridge 12 is the initial connection or the reconnection.
 図7のステップS1において、リモコン90の制御部91は、出力部95から、薬液投与装置10の装置本体14とカートリッジ12との間の接続が解除された後に、再度、接続が検出されたことをユーザに報知する。例えば、制御部91は、装置本体14とカートリッジ12との間の接続の解除及び再接続を検出した旨をディスプレイに表示することにより報知してもよい。制御部91は、薬液投与装置10から、装置本体14及びカートリッジ12の接続解除及び再接続の通知を受信したことに応じて、その旨を報知してもよい。また、薬液投与装置10の制御部71は、装置本体14とカートリッジ12とが接続され、電池42から電力が供給されたことに応じて起動するプログラムにおいて、通信部73を介して接続されたことをリモコン90に通知してもよい。その場合、薬液投与装置10は、その接続が装置本体14及びカートリッジ12の再接続であるかどうかを、入力部94を介したユーザ選択に基づいて判定してもよい。 In step S1 of FIG. 7, the control unit 91 of the remote controller 90 detects from the output unit 95 that the connection between the device main body 14 of the drug-solution administration device 10 and the cartridge 12 has been disconnected, and that the connection has been detected again. is notified to the user. For example, the control unit 91 may notify by displaying on the display that disconnection and reconnection between the apparatus main body 14 and the cartridge 12 have been detected. In response to receiving a notification of disconnection and reconnection between the device main body 14 and the cartridge 12 from the drug-solution administration device 10, the control unit 91 may notify that effect. The control unit 71 of the medicinal-solution administration device 10 is connected via the communication unit 73 in a program that is activated when the device main body 14 and the cartridge 12 are connected and power is supplied from the battery 42. may be notified to the remote controller 90 . In that case, the medical-solution administration device 10 may determine whether the connection is reconnection of the device main body 14 and the cartridge 12 based on the user's selection via the input unit 94 .
 ステップS2において、リモコン90の制御部91は、メンテナンス処理を実行する旨をユーザに報知する。例えば、制御部91は、メンテナンス処理を実行する旨を出力部95のディスプレイに表示してもよい。ここでいうメンテナンス処理とは、カートリッジ12と装置本体14の再接続に伴う、第2のプライミングの実行を指す。 In step S2, the control unit 91 of the remote controller 90 notifies the user that maintenance processing will be executed. For example, the control unit 91 may display on the display of the output unit 95 that maintenance processing is to be performed. The maintenance processing here refers to execution of the second priming accompanying reconnection of the cartridge 12 and the apparatus main body 14 .
 ステップS3において、リモコン90の制御部91は、薬液投与装置10をクレードルから外した状態で縦にするようにユーザに報知する。このとき、薬液投与装置10にクレードル検出スイッチを設けて、クレードルとの接続解除を判定してもよい。また、例えば、制御部91は、導出ポート28がリザーバ18の鉛直上方に位置するように薬液投与装置10を保持するようユーザに促す画像を出力部95のディスプレイに表示してもよい。また、制御部91は、姿勢検知部75が検知した薬液投与装置10の姿勢に基づき、薬液投与装置10の姿勢が適当でない場合にその旨を出力部95のディスプレイに表示し、薬液投与装置10の姿勢が適当となるまでステップS4への移行を保留してもよい。 In step S3, the control unit 91 of the remote controller 90 notifies the user to place the medicinal-solution administration device 10 vertically after removing it from the cradle. At this time, a cradle detection switch may be provided in the medical-solution administration device 10 to determine disconnection from the cradle. Further, for example, the control unit 91 may display on the display of the output unit 95 an image prompting the user to hold the medical-solution administration device 10 so that the outlet port 28 is positioned vertically above the reservoir 18 . If the attitude of the medicinal-solution administration device 10 detected by the attitude detection part 75 is not appropriate, the control unit 91 displays a message to that effect on the display of the output part 95 , and the medicinal-solution administration device 10 The transition to step S4 may be suspended until the posture of is appropriate.
 ステップS4において、リモコン90の制御部91は、開始ボタンを選択するようユーザに報知する。例えば、制御部91は、入力部94の開始ボタンの選択を促す画像を、出力部95のディスプレイに表示してもよい。入力部94が出力部95のディスプレイと一体的に設けられたタッチスクリーンである場合、制御部91は、開始ボタンの画像を出力部95のディスプレイに表示して、その選択を促す画像を表示してもよい。 In step S4, the control unit 91 of the remote controller 90 notifies the user to select the start button. For example, the control unit 91 may display an image prompting selection of the start button of the input unit 94 on the display of the output unit 95 . When the input unit 94 is a touch screen provided integrally with the display of the output unit 95, the control unit 91 displays an image of the start button on the display of the output unit 95, and displays an image prompting the selection. may
 ステップS5において、リモコン90の制御部91は、ユーザにより開始ボタンが選択されたか否かを判定する。制御部91は、開始ボタンが選択された場合(ステップS5でYES)は図8のステップS11へ進み、そうでない場合(ステップS5でNO)は開始ボタンが選択されるまで待機する。 In step S5, the control unit 91 of the remote controller 90 determines whether or not the start button has been selected by the user. If the start button is selected (YES in step S5), the control unit 91 proceeds to step S11 in FIG. 8, otherwise (NO in step S5), it waits until the start button is selected.
 図8のステップS11において、薬液投与装置10の制御部71は、モータ44を逆回転させる。すなわち、制御部71は、ナット部24を薬液の排出方向とは逆方向に移動するようにモータ44を回転させる。モータ44の逆回転によって、接続針管から空気がリザーバ18内に吸い込まれる。この逆回転の回転速度は、薬液を投与する際の通常の回転速度よりも大きくしてもよい。これにより、薬液投与の再開を短時間で行うことができる。制御部71は、開始ボタンが選択されたことの通知をリモコン90の通信部93から薬液投与装置10の通信部73で受信したことに応じて、ステップS11の処理を行ってもよい。 At step S11 in FIG. 8, the control unit 71 of the medicinal-solution administration device 10 rotates the motor 44 in the reverse direction. That is, the control section 71 rotates the motor 44 so as to move the nut section 24 in the direction opposite to the discharge direction of the chemical solution. Reverse rotation of the motor 44 draws air into the reservoir 18 from the connecting needle. The rotation speed of this reverse rotation may be greater than the normal rotation speed when administering the drug solution. As a result, it is possible to restart administration of the liquid medicine in a short time. The control unit 71 may perform the process of step S11 in response to receiving the notification that the start button has been selected from the communication unit 93 of the remote controller 90 by the communication unit 73 of the drug-solution administration device 10 .
 ステップS12において、薬液投与装置10の制御部71は、モータ44の脱調、又は、接触センサ74a~74dのいずれかとスライド部60との接触を検出したか否かを判定する。制御部71は、モータ44の脱調、又は、スライド部60の接触を検出した場合(ステップS12でYES)はステップS13へ進み、そうでない場合(ステップS12でNO)はステップS11においてモータ44の逆回転を継続する。モータ44の脱調の検出は、ナット部24が初期位置に達したことを意味する。 In step S12, the control unit 71 of the medicinal-solution administration device 10 determines whether or not the motor 44 is out of step, or contact between the slide unit 60 and any of the contact sensors 74a to 74d is detected. If the control unit 71 detects the step-out of the motor 44 or the contact of the slide unit 60 (YES in step S12), the process proceeds to step S13. Continue reverse rotation. Detection of step-out of the motor 44 means that the nut portion 24 has reached the initial position.
 ステップS13において、薬液投与装置10の制御部71は、モータ44の逆回転を停止する。 In step S<b>13 , the control unit 71 of the medicinal-solution administration device 10 stops the reverse rotation of the motor 44 .
 ステップS14において、薬液投与装置10の制御部71は、ステップS11でモータ44の逆回転を開始してからステップS13でモータ44の逆回転を停止するまでのモータ44の回転数Mを取得する。制御部71は、取得した回転数Mと、モータ44の脱調、又は、スライド部60の接触を検出した位置を通信部73からリモコン90に通知する。そして、制御部71は図9のステップS21へ進む。 In step S14, the control unit 71 of the medicinal-solution administration device 10 acquires the number of revolutions M of the motor 44 from the start of the reverse rotation of the motor 44 in step S11 to the stop of the reverse rotation of the motor 44 in step S13. The control unit 71 notifies the remote controller 90 of the obtained number of rotations M and the position at which the step-out of the motor 44 or the contact of the slide unit 60 is detected. Then, the controller 71 proceeds to step S21 in FIG.
 ステップS21において、薬液投与装置10の制御部71は、薬液投与装置10が所定の方向を向いているか否かを判定する。すなわち、制御部71は、姿勢検知部75が検知した薬液投与装置10の姿勢に基づき、導出ポート28がリザーバ18の鉛直上方に位置する方向に薬液投与装置10が保たれているか否かを判定する。この判定は、薬液投与装置10の姿勢が保たれていない場合に、モータ44の正回転によって接続針管から空気より先に薬液が排出されることを防ぐために行われる。制御部71は、薬液投与装置10が所定の方向を向いていると判定した場合(ステップS21でYES)はステップS22へ進み、そうでない場合(ステップS21でNO)はステップS25へ進む。 In step S21, the control unit 71 of the medicinal-solution administration device 10 determines whether or not the medicinal-solution administration device 10 faces a predetermined direction. That is, the control unit 71 determines whether or not the medical-solution administration device 10 is maintained in the direction in which the lead-out port 28 is positioned vertically above the reservoir 18 based on the posture of the medical-solution administration device 10 detected by the posture detection unit 75 . do. This determination is made to prevent the liquid medicine from being discharged from the connecting needle before the air due to the forward rotation of the motor 44 when the posture of the liquid medicine administration device 10 is not maintained. If the control unit 71 determines that the medicinal-solution administration device 10 faces the predetermined direction (YES in step S21), the process proceeds to step S22; otherwise (NO in step S21), the process proceeds to step S25.
 ステップS22において、薬液投与装置10の制御部71は、モータ44を正回転させる。モータ44の回転速度は、例えば、図8のステップS11におけるモータ44の逆回転と同様に、薬液を投与する際の通常の回転速度よりも大きくしてもよい。例えば、ステップS22における正回転の回転速度は、ステップS11の逆回転の回転速度と同一としてもよい。これにより、薬液投与の再開を短時間で行うことができる。このとき、導出ポート28がリザーバ18の鉛直上方を向いているため、モータ44の逆回転によって吸い込まれた空気が先にリザーバ18から排出される。 In step S22, the control unit 71 of the medicinal-solution administration device 10 causes the motor 44 to rotate forward. The rotational speed of the motor 44 may be, for example, higher than the normal rotational speed when administering the liquid medicine, similar to the reverse rotation of the motor 44 in step S11 of FIG. For example, the forward rotation speed in step S22 may be the same as the reverse rotation speed in step S11. As a result, it is possible to restart administration of the liquid medicine in a short time. At this time, since the outlet port 28 faces vertically above the reservoir 18 , the air sucked in by the reverse rotation of the motor 44 is first discharged from the reservoir 18 .
 ステップS23において、薬液投与装置10の制御部71は、ステップS22におけるモータ44の正回転の回転数がMであるか否かを判定する。制御部71は、正回転数がMの場合(ステップS23でYES)はステップS24へ進み、そうでない場合(ステップS23でNO)はステップS21へ進む。 In step S23, the control unit 71 of the medicinal-solution administration device 10 determines whether or not the number of forward rotations of the motor 44 in step S22 is M. If the forward rotation number is M (YES in step S23), the control unit 71 proceeds to step S24, otherwise (NO in step S23), proceeds to step S21.
 ステップS24において、薬液投与装置10の制御部71は、モータ44の正回転を停止する。そして、制御部71は図10のステップS31へ進む。 In step S24, the control unit 71 of the medicinal-solution administration device 10 stops forward rotation of the motor 44. Then, the controller 71 proceeds to step S31 in FIG.
 一方、ステップS25において、薬液投与装置10の制御部71は、モータ44が回転している場合、その回転を停止させる。すなわち、ステップS22でモータ44の正回転を開始した後、回転数がMになる前に、薬液投与装置10の姿勢が所定の方向からずれた場合、制御部71はモータ44の回転を停止させるともに、その旨をリモコン90に通知する。 On the other hand, in step S25, if the motor 44 is rotating, the control unit 71 of the medicinal-solution administration device 10 stops the rotation. That is, after starting forward rotation of the motor 44 in step S22, before the number of revolutions reaches M, if the posture of the drug-solution administration device 10 deviates from the predetermined direction, the control unit 71 stops the rotation of the motor 44. At the same time, the remote controller 90 is notified to that effect.
 ステップS26において、リモコン90の制御部91は、薬液投与装置10を縦にするようにユーザに報知する。例えば、制御部91は、ステップS3と同様に、導出ポート28がリザーバ18の鉛直上方に位置するように薬液投与装置10を保持するようユーザに促す画像を出力部95のディスプレイに表示してもよい。制御部91は、薬液投与装置10の姿勢が所定の方向からずれたことの通知を薬液投与装置10から受信したことに応じて、このような報知を行ってもよい。ステップS26の処理を終えるとステップS21へ戻り、薬液投与装置10の制御部71は薬液投与装置10の姿勢を確認する。 In step S26, the control unit 91 of the remote controller 90 notifies the user to turn the drug-solution administration device 10 vertically. For example, the control unit 91 may display on the display of the output unit 95 an image prompting the user to hold the medical-solution administration device 10 so that the lead-out port 28 is positioned vertically above the reservoir 18, as in step S3. good. The control unit 91 may make such notification in response to receiving from the medicinal-solution administration device 10 a notification that the posture of the medicinal-solution administration device 10 has deviated from the predetermined direction. After finishing the process of step S26, the process returns to step S21, and the control unit 71 of the medicinal-solution administration device 10 confirms the attitude of the medicinal-solution administration device 10. FIG.
 図10のステップS31において、リモコン90の制御部91は、送液ボタンを選択して薬液の吐出を確認するようユーザに報知する。この薬液の吐出は、第2のプライミングにおける薬液投与装置10の流路を薬液で充たす。例えば、制御部91は、入力部94の送液ボタンの選択を促す画像を、出力部95のディスプレイに表示してもよい。入力部94が出力部95のディスプレイと一体的に設けられたタッチスクリーンである場合、制御部91は、送液ボタンの画像を出力部95のディスプレイに表示して、その選択を促す画像を表示してもよい。制御部91は、ステップS24においてモータ44を停止したことの通知を薬液投与装置10から受信したことに応じて、薬液の吐出をユーザに促してもよい。 In step S31 of FIG. 10, the control unit 91 of the remote controller 90 notifies the user to select the liquid feed button and confirm the discharge of the liquid medicine. This ejection of the chemical liquid fills the flow path of the chemical liquid administration device 10 in the second priming with the chemical liquid. For example, the control section 91 may display on the display of the output section 95 an image prompting the user to select the liquid feeding button of the input section 94 . When the input unit 94 is a touch screen provided integrally with the display of the output unit 95, the control unit 91 displays an image of the liquid feeding button on the display of the output unit 95, and displays an image prompting selection thereof. You may The control unit 91 may prompt the user to discharge the liquid medicine in response to receiving the notification that the motor 44 has been stopped from the liquid medicine administration device 10 in step S24.
 ステップS32において、薬液投与装置10の制御部71は、リモコン90において送液ボタンが選択される毎に、一定回転数Nだけモータ44を正回転させて、リザーバ18内の薬液を導出管29の内孔へ移動させる。ステップS32において、制御部71は、図9のステップS22における正回転よりも遅い速度でモータ44を正回転させてもよい。また、リモコン90の制御部91は、薬液の吐出をユーザが確認した場合に、そのことを薬液投与装置10に通知するための画像(例えば、確認ボタン)を出力部95のディスプレイに表示してもよい。 In step S32, the control unit 71 of the medicinal-solution administration device 10 rotates the motor 44 forward by a constant number of rotations N each time the liquid feeding button is selected on the remote controller 90, thereby discharging the medicinal solution in the reservoir 18 into the lead-out tube 29. Move to inner hole. In step S32, the control unit 71 may rotate the motor 44 in the forward direction at a slower speed than the forward rotation in step S22 of FIG. Further, when the user confirms the discharge of the liquid medicine, the control unit 91 of the remote controller 90 displays an image (for example, a confirmation button) for notifying the liquid medicine administration device 10 of this on the display of the output unit 95. good too.
 ステップS33において、リモコン90の制御部91は、入力部94から薬液の吐出を確認したことがユーザから通知されたか否かを判定する。制御部91は、薬液吐出の確認が通知された場合(ステップS33でYES)はステップS34へ進み、そうでない場合(ステップS33でNO)はステップS31へ戻る。 In step S33, the control unit 91 of the remote controller 90 determines whether or not the user has notified from the input unit 94 that the discharge of the liquid medicine has been confirmed. If the confirmation of liquid medicine discharge has been notified (YES in step S33), the controller 91 proceeds to step S34; otherwise (NO in step S33), it returns to step S31.
 ステップS34において、リモコン90の制御部91は、モータ44の全正回転数と、ナット部24又はスライド部60の接触を検出した、初期位置又はいずれかの接触センサ74a~74dの位置とからリザーバ18内の薬液の残存量(充填量)を推定する。ここで、モータ44の全正回転数とは、ステップS22でモータの正回転を開始してからのモータ44の回転数の合計である。すなわち、モータ44の全正回転数は、図8のステップS14で取得したMと、ステップS32において送液ボタンが選択される毎に正回転させるモータ44の回転数Nに送液ボタンの選択回数を乗じた値との合計(M+N×選択回数)である。モータ44が1回転することによるナット部24の移動距離Lは、予め記憶部92(又は記憶部72)に記憶されていてもよい。その場合、制御部91は、L×(M+N×選択回数)によりナット部24の移動距離を求めてもよい。ナット部24の初期位置又は各接触センサ74a~74dの接触位置に対応するナット部24の位置も、予め記憶部92(又は記憶部72)に記憶されていてもよい。ここで、初期位置又は接触センサ74a~74dの位置は、それぞれ所定の薬液量に対応するように設定される。したがって、制御部91は、(1)逆回転を開始してから、最初にナット部24が到達する初期位置又は接触センサ74、(2)ナット部24が到達した初期位置又は接触センサ74に対応する所定の薬液量、(3)第2のプライミング完了時におけるモータ44の全正回転数(M+N×選択回数)又はナット部24の移動距離L、及び、(4)モータ44の1回転あたりまたはナット部24の単位移動距離あたりの薬液の排出量、の少なくともいずれかに基づき、薬液の残存量を推定して取得することができる。例えば、制御部91は、モータ44の全正回転数にモータ44の1回転あたりの薬液の排出量を乗じた値を、ナット部24の初期位置又は接触センサ74到達時のプランジャ20の位置でリザーバ18に充填できる薬液量から減ずることで薬液の残存量を推定してもよい。また、制御部91は、ナット部24が到達した初期位置又は接触センサ74の位置からナット部24の移動距離Lを減じてナット部24の位置を求めて、リザーバ18内の薬液の残存量を推定してもよい。例えば、ナット部24の位置と薬液の残存量との対応関係を予め記憶部92(又は記憶部72)に記憶しておき、制御部91は、その対応関係を参照して薬液の残存量を推定してもよい。 In step S34, the control unit 91 of the remote controller 90 selects a reservoir from the total number of normal rotations of the motor 44 and the initial position or the position of any one of the contact sensors 74a to 74d where the contact of the nut portion 24 or the slide portion 60 is detected. Estimate the remaining amount (filling amount) of the chemical solution in 18 . Here, the total number of forward rotations of the motor 44 is the total number of rotations of the motor 44 since the forward rotation of the motor was started in step S22. That is, the total number of forward rotations of the motor 44 is obtained by combining M obtained in step S14 of FIG. is the sum (M+N×number of selections) with the value multiplied by . The movement distance L of the nut portion 24 caused by one rotation of the motor 44 may be stored in advance in the memory portion 92 (or the memory portion 72). In that case, the controller 91 may obtain the moving distance of the nut part 24 by L×(M+N×the number of selections). The initial position of the nut portion 24 or the position of the nut portion 24 corresponding to the contact positions of the contact sensors 74a to 74d may also be stored in advance in the storage portion 92 (or the storage portion 72). Here, the initial positions or the positions of the contact sensors 74a to 74d are set so as to correspond to a predetermined amount of chemical solution. Therefore, the control unit 91 corresponds to (1) the initial position reached by the nut portion 24 or the contact sensor 74 first after the reverse rotation is started, and (2) the initial position reached by the nut portion 24 or the contact sensor 74. (3) the total number of positive rotations of the motor 44 (M + N × number of selections) or the movement distance L of the nut portion 24 at the completion of the second priming; and (4) per rotation of the motor 44 or Based on at least one of the discharge amount of the chemical solution per unit movement distance of the nut portion 24, the remaining amount of the chemical solution can be estimated and obtained. For example, the control unit 91 multiplies the total positive number of rotations of the motor 44 by the discharge amount of the chemical liquid per one rotation of the motor 44, at the initial position of the nut part 24 or the position of the plunger 20 when the contact sensor 74 reaches. The residual amount of the chemical solution may be estimated by subtracting it from the amount of the chemical solution that can be filled in the reservoir 18 . Further, the control unit 91 obtains the position of the nut portion 24 by subtracting the movement distance L of the nut portion 24 from the initial position reached by the nut portion 24 or the position of the contact sensor 74, and calculates the remaining amount of the chemical solution in the reservoir 18. can be estimated. For example, the correspondence relationship between the position of the nut portion 24 and the remaining amount of the chemical solution is stored in advance in the storage unit 92 (or the storage unit 72), and the control unit 91 refers to the correspondence relationship to determine the remaining amount of the chemical solution. can be estimated.
 ステップS35において、リモコン90の制御部91は、ステップS34で推定した薬液の残存量(充填量)を出力部95のディスプレイに表示する。そして、制御部91は、フローチャートの処理を終了する。 In step S35, the control unit 91 of the remote controller 90 displays the residual amount (filling amount) of the chemical liquid estimated in step S34 on the display of the output unit 95. Then, the control unit 91 ends the processing of the flowchart.
 以上のように、リザーバ18内に充填した薬液をプランジャ20の押圧作用により生体内に投与する薬液投与装置10は、リザーバ18、プランジャ20、ナット部24、駆動部40、位置検知部74、及び制御部71を備える。リザーバ18には薬液が充填される。プランジャ20は、リザーバ18内に設けられ、リザーバ18の長手方向に移動可能である。ナット部24は、可動領域において移動することにより、プランジャ20をリザーバ18の先端側に押圧することが可能である。駆動部40は、ナット部24を可動領域において移動させる。位置検知部74は、可動領域の予め定められた検知位置においてナット部24を検知することが可能である。制御部71は、中断した薬液投与を再開することが可能になったことに応じて、検知位置において位置検知部74がナット部24を検知するまで、ナット部24を先端側とは逆方向へ移動させる。制御部71は、当該逆方向への移動量である第1の移動量に基づき、リザーバ18における薬液の残存量を推定し、当該残存量に基づき薬液投与を再開するように、駆動部40を制御する。 As described above, the drug solution administration device 10 that administers the drug solution filled in the reservoir 18 into the living body by the pressing action of the plunger 20 includes the reservoir 18, the plunger 20, the nut portion 24, the drive portion 40, the position detection portion 74, and the A control unit 71 is provided. The reservoir 18 is filled with the chemical solution. A plunger 20 is provided within the reservoir 18 and is movable in the longitudinal direction of the reservoir 18 . The nut portion 24 can press the plunger 20 toward the distal end of the reservoir 18 by moving in the movable region. The driving part 40 moves the nut part 24 in the movable area. The position detection portion 74 can detect the nut portion 24 at a predetermined detection position in the movable area. In response to being able to resume the interrupted drug solution administration, the control unit 71 moves the nut part 24 in the direction opposite to the distal end side until the position detection part 74 detects the nut part 24 at the detection position. move. The control unit 71 estimates the remaining amount of the liquid medicine in the reservoir 18 based on the first movement amount, which is the amount of movement in the opposite direction, and operates the driving unit 40 so as to restart administration of the liquid medicine based on the remaining amount. Control.
 このように、薬液投与装置10は、中断した薬液投与が再開可能になった場合、初期位置ではなく、位置検知部74がナット部24を検知するまで、ナット部24を先端側とは逆方向へ移動させ、その移動量に基づき薬液の残存量を推定して、薬液投与を再開する。したがって、本実施形態に係る薬液投与装置10によれば、薬液投与が中断した場合に、薬液投与の再開に要する時間を短縮することが可能である。特に、薬液の初期充填量が少ない小児等においては、初期位置で第2のプライミングを行う場合に比べて、導出ポート28側に近い位置に設けられた位置検知部74によって第2のプライミングが可能になるため、第2のプライミングに要する時間及び電力消費量が大幅に削減できる。ナット部24の移動量は、例えばモータ44の回転数により示されるが、ナット部24の移動距離等の、ナット部24の移動の大きさを表す任意の単位により示されてもよい。また、薬液投与装置10は、ナット部24を先端側とは逆方向へ移動させる場合、薬液投与の動作中におけるナット部24の移動速度よりも速い速度でナット部24を移動させてもよい。これにより、薬液投与装置10は、薬液投与の再開に要する時間を更に短縮することが可能である。 In this way, when the drug-solution administration device 10 can resume the interrupted drug-solution administration, the nut portion 24 is moved in the direction opposite to the distal end side until the position detection portion 74 detects the nut portion 24 instead of the initial position. , the remaining amount of the chemical solution is estimated based on the amount of movement, and the administration of the chemical solution is resumed. Therefore, according to the medical-solution administration device 10 according to the present embodiment, it is possible to shorten the time required to resume the administration of the medical-solution when the administration of the medical-solution is interrupted. In particular, for infants, etc., where the initial amount of the drug solution to be filled is small, the second priming can be performed by the position detection unit 74 provided at a position closer to the outlet port 28 than when performing the second priming at the initial position. Therefore, the time and power consumption required for the second priming can be greatly reduced. The amount of movement of the nut portion 24 is indicated by, for example, the number of rotations of the motor 44, but may be indicated by any unit representing the magnitude of movement of the nut portion 24, such as the distance of movement of the nut portion 24. Further, when the nut portion 24 is moved in the direction opposite to the distal end side, the drug-solution administration device 10 may move the nut portion 24 at a faster speed than the movement speed of the nut portion 24 during the drug-solution administration operation. As a result, the medicinal-solution administration device 10 can further shorten the time required to restart medicinal-solution administration.
 また、制御部71は、ナット部24を検知位置から第1の移動量だけ先端側へ移動させてもよい。その移動後、制御部71は、薬液投与装置10における流路が薬液で充たされるまで、ナット部24を第2の移動量だけ先端側へ移動させた上で、薬液投与を再開するように、駆動部40を制御してもよい。このように、薬液投与装置10は、薬液投与が中断した場合の逆方向への移動量である第1の移動量だけナット部24を先端側へ移動させた上で、更に流路が薬液で充たされるまで、ナット部24を先端側へ移動させる。したがって、薬液投与装置10は、第2のプライミングに適した位置にナット部24を移動させるため、薬液投与の再開を短時間で行うことが可能である。薬液投与装置10は、ナット部24を検知位置から第1の移動量だけ先端側へ移動させる場合、薬液投与の動作中におけるナット部24の移動速度よりも速い速度でナット部24を移動させてもよい。これにより、薬液投与装置10は、薬液投与の再開に要する時間を更に短縮することが可能である。 Also, the control section 71 may move the nut section 24 from the detection position toward the distal end by the first movement amount. After that movement, the control unit 71 moves the nut part 24 by the second movement amount to the distal end side until the flow path in the medical-solution administration device 10 is filled with the medical solution, and then restarts the medical-solution administration. The drive unit 40 may be controlled. In this manner, the medicinal-solution administration device 10 moves the nut part 24 toward the distal end by the first amount of movement, which is the amount of movement in the opposite direction when the medicinal-solution administration is interrupted, and then the flow path is filled with the medicinal solution. The nut portion 24 is moved distally until it is filled. Therefore, since the medical-solution administration device 10 moves the nut portion 24 to a position suitable for the second priming, the medical-solution administration can be restarted in a short time. When the nut portion 24 is moved from the detection position to the distal end side by the first movement amount, the medicinal-solution administration device 10 moves the nut portion 24 at a faster speed than the movement speed of the nut portion 24 during the medicinal-solution administration operation. good too. As a result, the medicinal-solution administration device 10 can further shorten the time required to restart medicinal-solution administration.
 駆動部40は、モータ44の回転に基づく駆動力を伝達することにより、ナット部24を移動させてもよい。制御部71は、検知位置と、ナット部24が第1の移動量だけ移動するために必要なモータ44の回転数と、ナット部24が第2の移動量だけ移動するために必要なモータ44の回転数と、に基づき、薬液の残存量を推定してもよい。したがって、薬液投与装置10は、薬液の残存量を高い精度で推定することができる。 The driving section 40 may move the nut section 24 by transmitting driving force based on the rotation of the motor 44 . The control unit 71 controls the detection position, the number of rotations of the motor 44 necessary for moving the nut portion 24 by the first amount of movement, and the number of revolutions of the motor 44 necessary for moving the nut portion 24 by the second amount of movement. and the remaining amount of the chemical solution may be estimated. Therefore, the medicinal-solution administration device 10 can estimate the remaining amount of the medicinal solution with high accuracy.
 薬液投与装置10は、ナット部24の可動領域において、それぞれ異なる検知位置においてナット部24を検知することが可能な複数の位置検知部74a~74dを備えてもよい。制御部71は、中断した薬液投与を再開することが可能になったことに応じて、複数の位置検知部74a~74dのいずれかがナット部24を検知するまで、ナット部24を先端側とは逆方向へ移動させてもよい。このように、薬液投与装置10は、第2のプライミングにおいて、複数の位置検知部74a~74dのいずれかが検知するまでナット部24を先端(導出ポート28)側とは逆方向へ移動させるため、薬液投与の再開に要する時間を更に短縮することが可能である。図3及び図4は、薬液投与装置10が4つの位置検知部74a~74dを備えた例を示しているが、位置検知部74の個数は任意である。複数の位置検知部74を備えた場合、隣接する位置検知部74の間隔は同一の間隔としてもよいし、異なる間隔としてもよい。薬液投与装置10は、位置検知部74として、特定の位置においてナット部24を検出可能な複数の装置を備えるのではなく、ナット部24の可動領域の任意の位置においてナット部24を検出可能な装置を備えてもよい。 The medicinal-solution administration device 10 may include a plurality of position detection units 74a to 74d capable of detecting the nut portion 24 at different detection positions in the movable region of the nut portion 24. The control unit 71 moves the nut portion 24 toward the distal end side until any one of the plurality of position detection units 74a to 74d detects the nut portion 24 in response to being able to resume the interrupted drug solution administration. can be moved in the opposite direction. In this manner, in the second priming, the medicinal-solution administration device 10 moves the nut portion 24 in the direction opposite to the tip (outlet port 28) side until any one of the plurality of position detection portions 74a to 74d detects. , it is possible to further shorten the time required to restart administration of the liquid medicine. 3 and 4 show an example in which the medical-solution administration device 10 includes four position detectors 74a to 74d, but the number of position detectors 74 is arbitrary. When a plurality of position detectors 74 are provided, the intervals between adjacent position detectors 74 may be the same or different. The medical-solution administration device 10 does not include a plurality of devices capable of detecting the nut portion 24 at a specific position as the position detection portion 74, but can detect the nut portion 24 at any position in the movable region of the nut portion 24. device may be provided.
 薬液投与装置10は、使い捨てのカートリッジ12と、カートリッジ12に着脱可能に設けられた再利用可能な装置本体14と、を備えてもよい。リザーバ18、プランジャ20、ナット部24、駆動部40、位置検知部74、及び制御部71は、それぞれカートリッジ12又は装置本体14に設けられてもよい。制御部71は、薬液投与中に接続が解除されたカートリッジ12及び装置本体14が接続されたことに応じて、検知位置において位置検知部74がナット部24を検知するまで、ナット部24を先端側とは逆方向へ移動させてもよい。制御部71は、第1の移動量に基づきリザーバ18における薬液の残存量を推定し、当該残存量に基づき薬液投与を再開するように、駆動部40を制御してもよい。このように、薬液投与装置10をカートリッジ12及び装置本体14により構成した場合、薬液投与中に物体が接触するなどしてカートリッジ12及び装置本体14の接続が解除される場合があり得る。本実施形態に係る薬液投与装置10は、カートリッジ12及び装置本体14の接続に応じて、薬液投与を再開するための動作を開始するため、誤って接続が解除された場合に薬液投与の動作の再開を迅速に行うことが可能である。図3及び図4の例では、リザーバ18、プランジャ20、ナット部24、及び電池42はカートリッジ12に設けられ、駆動部40、位置検知部74、及び制御部71は装置本体14に設けられているが、このような構成に限られない。例えば、リザーバ18、プランジャ20、ナット部24、及び電池42の少なくともいずれかが装置本体14に設けられたり、駆動部40、位置検知部74、及び制御部71の少なくともいずれかがカートリッジ12に設けられたりしてもよい。また、薬液投与装置10は、使い捨てのカートリッジ12と、カートリッジ12に着脱可能に設けられた再利用可能な装置本体14とを備えるのではなく、例えば、全ての構成要素を再利用可能にしてもよい。 The drug-solution administration device 10 may include a disposable cartridge 12 and a reusable device body 14 detachably attached to the cartridge 12 . The reservoir 18, plunger 20, nut portion 24, drive portion 40, position detection portion 74, and control portion 71 may be provided in the cartridge 12 or the device main body 14, respectively. In response to the connection of the cartridge 12 and the device main body 14, which were disconnected during drug solution administration, the control unit 71 moves the nut portion 24 forward until the position detection unit 74 detects the nut portion 24 at the detection position. You may move it in the direction opposite to the side. The control unit 71 may estimate the amount of liquid medicine remaining in the reservoir 18 based on the first movement amount, and control the driving unit 40 to restart administration of the liquid medicine based on the remaining amount. When the liquid medicine administration device 10 is composed of the cartridge 12 and the device main body 14 in this way, there is a possibility that the cartridge 12 and the device main body 14 are disconnected due to contact with an object during liquid medicine administration. The medicinal-solution administration device 10 according to the present embodiment starts an operation for resuming medicinal-solution administration when the cartridge 12 and the device main body 14 are connected. It is possible to restart quickly. 3 and 4, the reservoir 18, the plunger 20, the nut portion 24, and the battery 42 are provided in the cartridge 12, and the drive portion 40, the position detection portion 74, and the control portion 71 are provided in the device main body 14. However, it is not limited to such a configuration. For example, at least one of the reservoir 18, the plunger 20, the nut portion 24, and the battery 42 is provided in the device main body 14, or at least one of the driving portion 40, the position detection portion 74, and the control portion 71 is provided in the cartridge 12. You may be taken. In addition, instead of including the disposable cartridge 12 and the reusable device main body 14 detachably attached to the cartridge 12, the drug-solution administration device 10 may be made reusable, for example, with all components. good.
 薬液投与装置10は、推定された薬液の残存量を表示装置に表示させてもよい。したがって、ユーザは、表示装置を参照して薬液の残存量を把握することができる。本実施形態の例では、薬液投与装置10は、リモコン90の出力部95のディスプレイに残存量を表示したが、薬液投与装置10自身が表示装置を備えている場合は、その表示装置に表示してもよい。また、薬液投与装置10は、例えば、スマートフォン、スマートウォッチ又はタブレット等の他の装置に薬液の残存量を通知して表示させてもよい。 The medicinal solution administration device 10 may display the estimated remaining amount of medicinal solution on the display device. Therefore, the user can grasp the remaining amount of the liquid medicine by referring to the display device. In the example of the present embodiment, the medicinal-solution administration device 10 displays the remaining amount on the display of the output unit 95 of the remote controller 90. However, if the medicinal-solution administration device 10 itself has a display device, the remaining amount is displayed on the display device. may In addition, the medicinal-solution administration device 10 may notify and display the remaining amount of the medicinal solution on another device such as a smart phone, a smart watch, or a tablet, for example.
 本開示は上述の実施形態に限定されない。例えば、ブロック図に記載の複数のブロックは統合されてもよいし、又は1つのブロックは分割されてもよい。フローチャートに記載の複数のステップは、記述に従って時系列に実行する代わりに、各ステップを実行する装置の処理能力に応じて、又は必要に応じて、並列的に又は異なる順序で実行されてもよい。その他、本開示の趣旨を逸脱しない範囲での変更が可能である。 The present disclosure is not limited to the above-described embodiments. For example, multiple blocks shown in the block diagrams may be combined, or a single block may be divided. Instead of being performed in chronological order according to the description, multiple steps described in the flowcharts may be performed in parallel or in a different order depending on the processing power of the device performing each step or as required. . Other modifications are possible without departing from the scope of the present disclosure.
10   薬液投与装置
  12   カートリッジ
  14   装置本体
  16   ベース部
  18   リザーバ
  20   プランジャ
  22   送りねじ軸
  24   ナット部
  26   導入ポート
  28   導出ポート
  29   導出管
  30   プランジャ本体
  32   押し子
  34   シール部材
  36   延出部
  38   爪部
  39   軸受
  40   駆動部
  42   電池
  44   モータ
  46   ギヤボックス
  48   出力歯車
  50   平歯車
  52   伝達軸
  54   端子
  56   軸受
  58   ナット部本体
  60   スライド部
  62   ねじ孔
  64   貫通孔
  66   補強カバー
  68   案内壁
  70   蓋体
  71   制御部
  72   記憶部
  73   通信部
  74   位置検知部(接触センサ)
  75   姿勢検知部
  79   バス
90   リモコン
  91   制御部
  92   記憶部
  93   通信部
  94   入力部
  95   出力部
  99   バス
100  薬液投与システム
 
 
 
REFERENCE SIGNS LIST 10 medicinal solution administration device 12 cartridge 14 device main body 16 base portion 18 reservoir 20 plunger 22 feed screw shaft 24 nut portion 26 introduction port 28 outlet port 29 outlet pipe 30 plunger main body 32 pusher 34 seal member 36 extension portion 38 claw portion 39 bearing 40 drive section 42 battery 44 motor 46 gear box 48 output gear 50 spur gear 52 transmission shaft 54 terminal 56 bearing 58 nut section main body 60 slide section 62 screw hole 64 through hole 66 reinforcement cover 68 guide wall 70 cover body 71 control section 72 memory Part 73 Communication part 74 Position detection part (contact sensor)
75 Attitude detection unit 79 Bus 90 Remote control 91 Control unit 92 Storage unit 93 Communication unit 94 Input unit 95 Output unit 99 Bus 100 Liquid administration system

Claims (8)

  1.  リザーバ内に充填した薬液をプランジャの押圧作用により生体内に投与する薬液投与装置であって、
     前記薬液が充填される前記リザーバと、
     前記リザーバ内に設けられ、前記リザーバの長手方向に移動可能な前記プランジャと、
     可動領域において移動することにより、前記プランジャを前記リザーバの先端側に押圧することが可能な可動部と、
     前記可動部を前記可動領域において移動させる駆動部と、
     前記可動領域の予め定められた検知位置において前記可動部を検知することが可能な検知部と、
     制御部と、
     を備え、
     前記制御部は、前記検知位置において前記検知部が前記可動部を検知するまで、前記可動部を前記先端側とは逆方向へ移動させ、当該逆方向への移動量である第1の移動量に基づき、前記リザーバにおける前記薬液の残存量を推定する、
     薬液投与装置。
    A drug solution administration device for administering a drug solution filled in a reservoir into a living body by a pressing action of a plunger,
    the reservoir filled with the chemical solution;
    the plunger disposed within the reservoir and movable longitudinally of the reservoir;
    a movable part capable of pressing the plunger toward the distal end of the reservoir by moving in the movable area;
    a drive unit that moves the movable unit in the movable area;
    a detection unit capable of detecting the movable portion at a predetermined detection position in the movable area;
    a control unit;
    with
    The control section moves the movable section in a direction opposite to the distal end side until the detection section detects the movable section at the detection position, and a first movement amount is a movement amount in the opposite direction. estimating the remaining amount of the drug solution in the reservoir based on
    Chemical liquid administration device.
  2.  前記制御部は、前記可動部を前記検知位置から前記第1の移動量だけ前記先端側へ移動させ、当該移動後、前記薬液投与装置における流路が前記薬液で充たされるまで、前記可動部を第2の移動量だけ前記先端側へ移動させた上で、前記薬液投与を再開するように、前記駆動部を制御する、請求項1に記載の薬液投与装置。 The control unit moves the movable part from the detection position to the distal end side by the first movement amount, and after the movement, moves the movable part until the flow path in the medical-solution administration device is filled with the medical solution. 2. The medical-solution administration device according to claim 1, wherein said drive unit is controlled so as to restart administration of said medical-solution after being moved to said distal end side by a second movement amount.
  3.  前記駆動部は、モータの回転に基づく駆動力を伝達することにより、前記可動部を移動させ、
     前記制御部は、前記検知位置と、前記可動部が前記第1の移動量だけ移動するために必要な前記モータの回転数と、前記可動部が前記第2の移動量だけ移動するために必要な前記モータの回転数と、に基づき、前記薬液の残存量を推定する、
     請求項2に記載の薬液投与装置。
    The drive unit moves the movable unit by transmitting a driving force based on rotation of a motor,
    The controller controls the detection position, the number of revolutions of the motor required for the movable part to move by the first movement amount, and the number of rotations required for the movable part to move by the second movement amount. estimating the remaining amount of the chemical solution based on the number of rotations of the motor, and
    The drug-solution administration device according to claim 2.
  4.  それぞれ異なる前記検知位置において前記可動部を検知することが可能な複数の前記検知部を備え、
     前記制御部は、中断した薬液投与を再開することが可能になったことに応じて、前記複数の検知部のいずれかが前記可動部を検知するまで、前記可動部を前記先端側とは逆方向へ移動させる、
     請求項1から3のいずれか一項に記載の薬液投与装置。
    A plurality of the detection units capable of detecting the movable portion at the detection positions different from each other,
    In response to being able to resume the interrupted drug solution administration, the control section moves the movable section in the opposite direction to the distal end side until any one of the plurality of detection sections detects the movable section. move in the direction of
    The drug-solution administration device according to any one of claims 1 to 3.
  5.  使い捨てのカートリッジと、
     前記カートリッジに着脱可能に設けられた再利用可能な装置本体と、
     を備え、
     前記リザーバ、前記プランジャ、前記可動部、前記駆動部、前記検知部、及び前記制御部は、それぞれ前記カートリッジ又は前記装置本体に設けられ、
     前記制御部は、
     薬液投与中に接続が解除された前記カートリッジ及び前記装置本体が再び接続されたことに応じて、前記検知位置において前記検知部が前記可動部を検知するまで、前記可動部を前記先端側とは逆方向へ移動させ、前記第1の移動量に基づき前記リザーバにおける前記薬液の残存量を推定し、当該残存量に基づき前記薬液投与を再開するように、前記駆動部を制御する、
     請求項1から4のいずれか一項に記載の薬液投与装置。
    disposable cartridges and
    a reusable apparatus main body detachably attached to the cartridge;
    with
    the reservoir, the plunger, the movable portion, the drive portion, the detection portion, and the control portion are provided in the cartridge or the device main body, respectively;
    The control unit
    until the detection unit detects the movable portion at the detection position in response to reconnection of the cartridge and the apparatus main body that were disconnected during the administration of the liquid medicine, and the movable portion is separated from the distal end side. moving in the opposite direction, estimating the remaining amount of the medical solution in the reservoir based on the first movement amount, and controlling the driving unit to restart administration of the medical solution based on the remaining amount;
    The drug-solution administration device according to any one of claims 1 to 4.
  6.  推定された前記薬液の残存量を表示装置に表示させる、請求項1から5のいずれか一項に記載の薬液投与装置。 The medicinal-solution administration device according to any one of claims 1 to 5, wherein the estimated remaining amount of the medicinal solution is displayed on a display device.
  7.  請求項1から6のいずれか一項に記載の薬液投与装置と、
     ユーザが前記薬液投与装置を操作するためのリモコンと、
     を備える薬液投与システム。
    a drug-solution administration device according to any one of claims 1 to 6;
    a remote controller for a user to operate the medical-solution administration device;
    A drug delivery system comprising:
  8.  薬液が充填されるリザーバと、
     前記リザーバ内に設けられ、前記リザーバの長手方向に移動可能なプランジャと、
     可動領域において移動することにより、前記プランジャを前記リザーバの先端側に押圧することが可能な可動部と、
     前記可動部を前記可動領域において移動させる駆動部と、
     前記可動領域の予め定められた検知位置において前記可動部を検知することが可能な検知部と、
     制御部と、
     を備え、前記リザーバ内に充填した前記薬液を前記プランジャの押圧作用により生体内に投与する薬液投与装置の制御方法であって、
     前記制御部が、前記検知位置において前記検知部が前記可動部を検知するまで、前記可動部を前記先端側とは逆方向へ移動させ、当該逆方向への移動量である第1の移動量に基づき、前記リザーバにおける前記薬液の残存量を推定する、
     薬液投与装置の制御方法。
     
     
    a reservoir filled with a chemical solution;
    a plunger disposed within the reservoir and movable longitudinally of the reservoir;
    a movable part capable of pressing the plunger toward the distal end of the reservoir by moving in the movable area;
    a drive unit that moves the movable unit in the movable area;
    a detection unit capable of detecting the movable portion at a predetermined detection position in the movable area;
    a control unit;
    A control method for a drug-solution administration device that administers the drug solution filled in the reservoir into the living body by the pressing action of the plunger,
    The control section moves the movable section in a direction opposite to the tip end side until the detection section detects the movable section at the detection position, and a first movement amount is a movement amount in the opposite direction. estimating the remaining amount of the drug solution in the reservoir based on
    A control method for a drug-solution administration device.

PCT/JP2022/034106 2022-01-07 2022-09-12 Liquid drug administration device, method for controlling same, and liquid drug administration system WO2023132104A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2022001898 2022-01-07
JP2022-001898 2022-01-07

Publications (1)

Publication Number Publication Date
WO2023132104A1 true WO2023132104A1 (en) 2023-07-13

Family

ID=87073389

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2022/034106 WO2023132104A1 (en) 2022-01-07 2022-09-12 Liquid drug administration device, method for controlling same, and liquid drug administration system

Country Status (1)

Country Link
WO (1) WO2023132104A1 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009526565A (en) * 2006-02-14 2009-07-23 バテル メモリアル インスティチュート Accurate measurement system
WO2016132937A1 (en) * 2015-02-20 2016-08-25 テルモ株式会社 Liquid drug administration device
JP2016527938A (en) * 2013-06-28 2016-09-15 アニマス・コーポレイション Drug injection device with safety protection device
JP2019506228A (en) * 2016-02-26 2019-03-07 イーライ リリー アンド カンパニー Reusable drug delivery device with residual drug determination capability

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009526565A (en) * 2006-02-14 2009-07-23 バテル メモリアル インスティチュート Accurate measurement system
JP2016527938A (en) * 2013-06-28 2016-09-15 アニマス・コーポレイション Drug injection device with safety protection device
WO2016132937A1 (en) * 2015-02-20 2016-08-25 テルモ株式会社 Liquid drug administration device
JP2019506228A (en) * 2016-02-26 2019-03-07 イーライ リリー アンド カンパニー Reusable drug delivery device with residual drug determination capability

Similar Documents

Publication Publication Date Title
US11554209B2 (en) Systems, apparatuses and methods for fluid infusion into a body
US10828430B2 (en) Medicinal-liquid administering device
EP2705453B1 (en) System for optimizing a drug dosage regimen over time
US10792424B2 (en) Liquid medicine administration device
JP4480330B2 (en) Improvements to and related to infusion devices
JP2016525381A (en) Drug delivery device and system with dose preset function
WO2016151973A1 (en) Device for administering liquid medicine
WO2023132104A1 (en) Liquid drug administration device, method for controlling same, and liquid drug administration system
US20210369952A1 (en) Drug solution delivery apparatus
WO2023166864A1 (en) Liquid drug administration device, method for controlling same, and liquid drug administration system
US20220008650A1 (en) Liquid medicine administration device
JP7162055B2 (en) Chemical-solution administration device and control method for chemical-solution administration device
WO2023166865A1 (en) Liquid drug administration device, method for controlling same, and liquid drug administration system
WO2023132103A1 (en) Medicinal solution administration device, control method thereof, and medicinal solution administration system
JP6438822B2 (en) Chemical solution administration device
US20210338938A1 (en) Injection Apparatus
JP2023127492A (en) Liquid medicine administration device, control method thereof, and liquid medicine administration system
JP2023127494A (en) Liquid medicine administration device, control method thereof, and liquid medicine administration system
WO2020203004A1 (en) Liquid medicine administration apparatus
WO2020202922A1 (en) Liquid medicine administration apparatus
JP2023540070A (en) Drug injection device, drug injection device and method for determining the remaining drug amount

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 22918693

Country of ref document: EP

Kind code of ref document: A1